Scott Lippman

Title(s)Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Targeting Signaling Vulnerabilities for Oral Cancer Prevention
    NIH R01DE026644Jan 1, 2017 - Dec 31, 2021
    Role: Co-Principal Investigator
    Molecular-Based Therapy for Oral Cancer Prevention
    NIH P01CA106451Aug 1, 2004 - Jul 31, 2012
    Role: Principal Investigator
    U10 Full Member Application Affiliated with SWOG
    NIH U10CA105409Jul 26, 2004 - Dec 31, 2015
    Role: Principal Investigator
    Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
    NIH N01CN35159-8-0-1Sep 30, 2003 - Sep 29, 2012
    Role: Principal Investigator
    M D Anderson Cancer Center Head & Neck SPORE
    NIH P50CA097007Sep 30, 2002 - Jul 31, 2015
    Role: Principal Investigator
    PHASE III STUDY OF FENRETINIDE IN BLADDER CARCINOFENESIS
    NIH U01CA077150Sep 30, 1997 - Jul 31, 2004
    Role: Principal Investigator
    BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH &PROGRESSION
    NIH P01CA068233May 6, 1996 - Mar 31, 2005
    Role: Co-Investigator
    PHASE II CLINICAL TRIALS OF NEW CHEMOPRVENTIVE AGENTS
    NIH/NCI N01CN065004Oct 2, 1995 - Jun 30, 2000
    Role: Principal Investigator
    BIOLOGY AND CHEMOPREVENTION OF HEAD AND NECK CANCER
    NIH P01CA052051Aug 5, 1991 - Nov 30, 2004
    Role: Co-Investigator
    Specialized Cancer Center Support Grant
    NIH P30CA023100Apr 1, 1978 - Apr 30, 2024
    Role: Principal Investigator
    Biology of the Prostate Cancer Prevention Trial (PCPT)
    NIH P01CA108964Apr 30, 2014
    Role: Principal Investigator
    Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
    NIH/NCI N01CN35159Sep 29, 2008
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. If it's a target, it's a pan-cancer target: Tissue is not the issue. Cancer Treat Rev. 2024 Mar 21; 125:102721. Adashek JJ, Kato S, Sicklick JK, Lippman SM, Kurzrock R. PMID: 38522181.
      View in: PubMed   Mentions:    Fields:    
    2. A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer. Sci Transl Med. 2024 Feb 28; 16(736):eabj9905. Miller AM, Kosaloglu-Yalçin Z, Westernberg L, Montero L, Bahmanof M, Frentzen A, Lanka M, Logandha Ramamoorthy Premlal A, Seumois G, Greenbaum J, Brightman SE, Soria Zavala K, Thota RR, Naradikian MS, Makani SS, Lippman SM, Sette A, Cohen EEW, Peters B, Schoenberger SP. PMID: 38416845.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study. Gastroenterology. 2024 Feb 05. Rodriguez NJ, Furniss CS, Yurgelun MB, Ukaegbu C, Constantinou PE, Fortes I, Caruso A, Schwartz AN, Stopfer JE, Underhill-Blazey M, Kenner B, Nelson SH, Okumura S, Zhou AY, Coffin TB, Uno H, Horiguchi M, Ocean AJ, McAllister F, Lowy AM, Klein AP, Madlensky L, Petersen GM, Garber JE, Lippman SM, Goggins MG, Maitra A, Syngal S. PMID: 38320723.
      View in: PubMed   Mentions:    Fields:    
    4. Integrated germline and somatic features reveal divergent immune pathways driving ICB response. bioRxiv. 2024 Jan 15. Sears T, Pagadala M, Castro A, Lee KH, Kong J, Tanaka K, Lippman S, Zanetti M, Carter H. PMID: 38293085; PMCID: PMC10827124.
      View in: PubMed   Mentions:
    5. High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome. Ther Adv Med Oncol. 2024; 16:17588359231220510. Krishnamurthy N, Nishizaki D, Lippman SM, Miyashita H, Nesline MK, Pabla S, Conroy JM, DePietro P, Kato S, Kurzrock R. PMID: 38188465; PMCID: PMC10771755.
      View in: PubMed   Mentions:
    6. Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jan 01; 10(1):32-41. Hanna GJ, Villa A, Nandi SP, Shi R, ONeill A, Liu M, Quinn CT, Treister NS, Sroussi HY, Vacharotayangul P, Goguen LA, Annino DJ, Rettig EM, Jo VY, Wong KS, Lizotte P, Paweletz CP, Uppaluri R, Haddad RI, Cohen EEW, Alexandrov LB, William WN, Lippman SM, Woo SB. PMID: 37971722; PMCID: PMC10654930.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Pan-cancer analysis of TIM-3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity. Cancer Med. 2023 Dec 22. Lim J, Kurzrock R, Nishizaki D, Miyashita H, Adashek JJ, Lee S, Pabla S, Nesline M, Conroy JM, DePietro P, Lippman SM, Kato S. PMID: 38132831; PMCID: PMC10807558.
      View in: PubMed   Mentions: 1     Fields:    
    8. Considering molecular alterations as pan-cancer tissue-agnostic targets. Nat Cancer. 2023 Dec; 4(12):1622-1626. Adashek JJ, Kato S, Sicklick JK, Lippman SM, Kurzrock R. PMID: 38102355.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse. J Immunother Precis Oncol. 2023 Aug; 6(3):127-132. Castro A, Goodman AM, Rane Z, Talwar JV, Frampton GM, Morris GP, Lippman SM, Zhang X, Kurzrock R, Carter H. PMID: 37637234; PMCID: PMC10448732.
      View in: PubMed   Mentions:
    10. LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics. Cancer Med. 2023 06; 12(12):13155-13166. Adashek JJ, Kato S, Nishizaki D, Miyashita H, De P, Lee S, Pabla S, Nesline M, Conroy JM, DePietro P, Lippman S, Kurzrock R. PMID: 37132280; PMCID: PMC10315766.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    11. KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres. Cell. 2023 04 27; 186(9):1985-2001.e19. Bosco N, Goldberg A, Zhao X, Mays JC, Cheng P, Johnson AF, Bianchi JJ, Toscani C, Di Tommaso E, Katsnelson L, Annuar D, Mei S, Faitelson RE, Pesselev IY, Mohamed KS, Mermerian A, Camacho-Hernandez EM, Gionco CA, Manikas J, Tseng YS, Sun Z, Fani S, Keegan S, Lippman SM, Fenyö D, Giunta S, Santaguida S, Davoli T. PMID: 37075754; PMCID: PMC10676289.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    12. Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus. Nature. 2023 04; 616(7958):798-805. Luebeck J, Ng AWT, Galipeau PC, Li X, Sanchez CA, Katz-Summercorn AC, Kim H, Jammula S, He Y, Lippman SM, Verhaak RGW, Maley CC, Alexandrov LB, Reid BJ, Fitzgerald RC, Paulson TG, Chang HY, Wu S, Bafna V, Mischel PS. PMID: 37046089; PMCID: PMC10132967.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    13. Chromosomal fragile site breakage by EBV-encoded EBNA1 at clustered repeats. Nature. 2023 04; 616(7957):504-509. Li JSZ, Abbasi A, Kim DH, Lippman SM, Alexandrov LB, Cleveland DW. PMID: 37046091; PMCID: PMC10328181.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    14. Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real-world precision-medicine population. Mol Oncol. 2023 09; 17(9):1844-1856. Rosenberg S, Ben Cohen G, Kato S, Okamura R, Lippman SM, Kurzrock R. PMID: 36694946; PMCID: PMC10483598.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Cancer, more than a "COVID-19 co-morbidity". Front Oncol. 2023; 13:1107384. Jani CT, Schooley RT, Mckay RR, Lippman SM. PMID: 36994197; PMCID: PMC10040761.
      View in: PubMed   Mentions: 2  
    16. Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors. Oncologist. 2023 02 08; 28(2):e82-e91. Jardim DLF, Millis SZ, Ross JS, Lippman S, Ali SM, Kurzrock R. PMID: 36082904; PMCID: PMC9907036.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia. Cancer Med. 2023 03; 12(6):7508-7518. Zhang X, Gleber-Netto FO, Wang S, Martins-Chaves RR, Gomez RS, Vigneswaran N, Sarkar A, William WN, Papadimitrakopoulou V, Williams M, Bell D, Palsgrove D, Bishop J, Heymach JV, Gillenwater AM, Myers JN, Ferrarotto R, Lippman SM, Pickering CR, Xiao G. PMID: 36721313; PMCID: PMC10067069.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort. Cancer. 2023 03 01; 129(5):714-727. William WN, Zhang J, Zhao X, Parra ER, Uraoka N, Lin HY, Peng SA, El-Naggar AK, Rodriguez-Canales J, Song J, Gillenwater AM, Wistuba II, Myers JN, Gold KA, Ferrarotto R, Hwu P, Davoli T, Lee JJ, Heymach JV, Papadimitrakopoulou VA, Lippman SM. PMID: 36597662; PMCID: PMC10508302.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    19. Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ-focal adhesion kinase signaling circuitry. J Biol Chem. 2023 02; 299(2):102866. Arang N, Lubrano S, Rigiracciolo DC, Nachmanson D, Lippman SM, Mali P, Harismendy O, Gutkind JS. PMID: 36596361; PMCID: PMC9922814.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    20. JAK: Not Just Another Kinase. Mol Cancer Ther. 2022 12 02; 21(12):1757-1764. Agashe RP, Lippman SM, Kurzrock R. PMID: 36252553; PMCID: PMC10441554.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    21. Somatic 9p24.1 alterations in HPV- head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activity. Proc Natl Acad Sci U S A. 2022 11 22; 119(47):e2213835119. Zhao X, Cohen EEW, William WN, Bianchi JJ, Abraham JP, Magee D, Spetzler DB, Gutkind JS, Alexandrov LB, Cavenee WK, Lippman SM, Davoli T. PMID: 36395141; PMCID: PMC9704728.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    22. AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas. JCI Insight. 2022 09 22; 7(18). Ghosh P, Campos VJ, Vo DT, Guccione C, Goheen-Holland V, Tindle C, Mazzini GS, He Y, Alexandrov LB, Lippman SM, Gurski RR, Das S, Yadlapati R, Curtius K, Sahoo D. PMID: 36134663; PMCID: PMC9675486.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy. NPJ Precis Oncol. 2022 Sep 22; 6(1):67. Louie BH, Kato S, Kim KH, Lim HJ, Okamura R, Eskander RN, Botta G, Patel H, Lee S, Lippman SM, Sicklick JK, Kurzrock R. PMID: 36138116; PMCID: PMC9500013.
      View in: PubMed   Mentions: 2  
    24. Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathways. Elife. 2022 09 21; 11. Cheng P, Zhao X, Katsnelson L, Camacho-Hernandez EM, Mermerian A, Mays JC, Lippman SM, Rosales-Alvarez RE, Moya R, Shwetar J, Grun D, Fenyo D, Davoli T. PMID: 36129397; PMCID: PMC9491860.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    25. Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test. Commun Med (Lond). 2022; 2:29. Hinestrosa JP, Kurzrock R, Lewis JM, Schork NJ, Schroeder G, Kamat AM, Lowy AM, Eskander RN, Perrera O, Searson D, Rastegar K, Hughes JR, Ortiz V, Clark I, Balcer HI, Arakelyan L, Turner R, Billings PR, Adler MJ, Lippman SM, Krishnan R. PMID: 35603292; PMCID: PMC9053211.
      View in: PubMed   Mentions: 26  
    26. Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be golden. J Hematol Oncol. 2021 12 02; 14(1):201. Boichard A, Lippman SM, Kurzrock R. PMID: 34857015; PMCID: PMC8638100.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    27. Asymptomatic detection of SARS-CoV-2 among cancer patients receiving infusional anti-cancer therapy. Cancer Med. 2021 12; 10(24):8763-8767. Shaya J, Cabal A, Nonato T, Torriani F, Califano J, Lippman S, Sacco A, McKay RR. PMID: 34708934; PMCID: PMC8646446.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    28. Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Cancer Prev Res (Phila). 2021 11; 14(11):1021-1032. Furniss CS, Yurgelun MB, Ukaegbu C, Constantinou PE, Lafferty CC, Talcove-Berko ER, Schwartz AN, Stopfer JE, Underhill-Blazey M, Kenner B, Nelson SH, Okumura S, Law S, Zhou AY, Coffin TB, Rodriguez NJ, Uno H, Ocean AJ, McAllister F, Lowy AM, Lippman SM, Klein AP, Madlensky L, Petersen GM, Garber JE, Goggins MG, Maitra A, Syngal S. PMID: 34625409; PMCID: PMC8563400.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    29. Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study. Genome Med. 2021 10 04; 13(1):155. Sicklick JK, Kato S, Okamura R, Patel H, Nikanjam M, Fanta PT, Hahn ME, De P, Williams C, Guido J, Solomon BM, McKay RR, Krie A, Boles SG, Ross JS, Lee JJ, Leyland-Jones B, Lippman SM, Kurzrock R. PMID: 34607609; PMCID: PMC8491393.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    30. Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions. JCI Insight. 2021 09 08; 6(17). Gutkind JS, Molinolo AA, Wu X, Wang Z, Nachmanson D, Harismendy O, Alexandrov LB, Wuertz BR, Ondrey FG, Laronde D, Rock LD, Rosin M, Coffey C, Butler VD, Bengtson L, Hsu CH, Bauman JE, Hewitt SM, Cohen EE, Chow HS, Lippman SM, Szabo E. PMID: 34255745; PMCID: PMC8492350.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    31. Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response. Clin Cancer Res. 2022 01 01; 28(1):187-200. Yebra M, Bhargava S, Kumar A, Burgoyne AM, Tang CM, Yoon H, Banerjee S, Aguilera J, Cordes T, Sheth V, Noh S, Ustoy R, Li S, Advani SJ, Corless CL, Heinrich MC, Kurzrock R, Lippman SM, Fanta PT, Harismendy O, Metallo C, Sicklick JK. PMID: 34426440; PMCID: PMC8738129.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    32. Immune evasion in HPV- head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss. Proc Natl Acad Sci U S A. 2021 05 11; 118(19). William WN, Zhao X, Bianchi JJ, Lin HY, Cheng P, Lee JJ, Carter H, Alexandrov LB, Abraham JP, Spetzler DB, Dubinett SM, Cleveland DW, Cavenee W, Davoli T, Lippman SM. PMID: 33952700; PMCID: PMC8126856.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    33. Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial. Lancet Oncol. 2021 06; 22(6):883-892. Sacco AG, Chen R, Worden FP, Wong DJL, Adkins D, Swiecicki P, Chai-Ho W, Oppelt P, Ghosh D, Bykowski J, Molinolo A, Pittman E, Estrada MV, Gold K, Daniels G, Lippman SM, Natsuhara A, Messer K, Cohen EEW. PMID: 33989559.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCTClinical Trials
    34. Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial. Nutr Cancer. 2022; 74(1):141-148. Chadid S, Song X, Schenk JM, Gurel B, Lucia MS, Thompson IM, Neuhouser ML, Goodman PJ, Parnes HL, Lippman SM, Nelson WG, De Marzo AM, Platz EA. PMID: 33511883; PMCID: PMC8319215.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    35. Attrition of Patients on a Precision Oncology Trial: Analysis of the I-PREDICT Experience. Oncologist. 2020 11; 25(11):e1803-e1806. Bohan SS, Sicklick JK, Kato S, Okamura R, Miller VA, Leyland-Jones B, Lippman SM, Kurzrock R. PMID: 32949172; PMCID: PMC7648352.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy. Nat Commun. 2020 10 02; 11(1):4965. Kato S, Kim KH, Lim HJ, Boichard A, Nikanjam M, Weihe E, Kuo DJ, Eskander RN, Goodman A, Galanina N, Fanta PT, Schwab RB, Shatsky R, Plaxe SC, Sharabi A, Stites E, Adashek JJ, Okamura R, Lee S, Lippman SM, Sicklick JK, Kurzrock R. PMID: 33009371; PMCID: PMC7532150.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    37. Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing. Cell Metab. 2020 11 03; 32(5):704-709. Evans RM, Lippman SM. PMID: 32941797; PMCID: PMC7486067.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    38. The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial. Prostate. 2020 08; 80(11):895-905. Chadid S, Barber JR, Nelson WG, Gurel B, Lucia MS, Thompson IM, Goodman PJ, Stanczyk FZ, Parnes HL, Lippman SM, De Marzo AM, Platz EA. PMID: 32506665; PMCID: PMC7384586.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Author Correction: Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan. Sci Rep. 2020 Mar 23; 10(1):5514. Wu X, Wen CP, Ye Y, Tsai M, Wen C, Roth JA, Pu X, Chow WH, Huff C, Cunningham S, Huang M, Wu S, Tsao CK, Gu J, Lippman SM. PMID: 32251345; PMCID: PMC7090032.
      View in: PubMed   Mentions:    Fields:    
    40. A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors After Curative-Intent Treatment. Am J Phys Med Rehabil. 2020 03; 99(3):233-240. Ha D, Kerr J, Ries AL, Fuster MM, Lippman SM, Murphy JD. PMID: 31361623; PMCID: PMC6982544.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    41. The paradox of cancer genes in non-malignant conditions: implications for precision medicine. Genome Med. 2020 02 17; 12(1):16. Adashek JJ, Kato S, Lippman SM, Kurzrock R. PMID: 32066498; PMCID: PMC7027240.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    42. Prognostic implications of RAS alterations in diverse malignancies and impact of targeted therapies. Int J Cancer. 2020 06 15; 146(12):3450-3460. Kato S, Okamura R, Sicklick JK, Daniels GA, Hong DS, Goodman A, Weihe E, Lee S, Khalid N, Collier R, Mareboina M, Riviere P, Whitchurch TJ, Fanta PT, Lippman SM, Kurzrock R. PMID: 31782524; PMCID: PMC10200262.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    43. Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes. Support Care Cancer. 2020 Oct; 28(10):4707-4720. Ha D, Ries AL, Lippman SM, Fuster MM. PMID: 31965306; PMCID: PMC7371511.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    44. Targeting mTOR in Head and Neck Cancer-Response. Clin Cancer Res. 2019 11 01; 25(21):6555. Gutkind JS, Day TA, Lippman SM, Szabo E. PMID: 31676588; PMCID: PMC10224677.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    45. Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy. Cancer Immunol Res. 2019 10; 7(10):1570-1573. Goodman AM, Sokol ES, Frampton GM, Lippman SM, Kurzrock R. PMID: 31405947; PMCID: PMC6774837.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansCells
    46. Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics. Mol Cancer Ther. 2019 10; 18(10):1852-1862. Choi IS, Kato S, Fanta PT, Leichman L, Okamura R, Raymond VM, Lanman RB, Lippman SM, Kurzrock R. PMID: 31320401.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    47. Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells. Cancer Res. 2019 09 01; 79(17):4360-4370. Wu X, Yeerna H, Goto Y, Ando T, Wu VH, Zhang X, Wang Z, Amornphimoltham P, Murphy AN, Tamayo P, Chen Q, Lippman SM, Gutkind JS. PMID: 31292160; PMCID: PMC6726568.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    48. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. Nat Med. 2019 05; 25(5):744-750. Sicklick JK, Kato S, Okamura R, Schwaederle M, Hahn ME, Williams CB, De P, Krie A, Piccioni DE, Miller VA, Ross JS, Benson A, Webster J, Stephens PJ, Lee JJ, Fanta PT, Lippman SM, Leyland-Jones B, Kurzrock R. PMID: 31011206; PMCID: PMC6553618.
      View in: PubMed   Mentions: 247     Fields:    Translation:HumansCTClinical Trials
    49. 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer. Cancer Res. 2019 04 01; 79(7):1438-1450. Wang Z, Feng X, Molinolo AA, Martin D, Vitale-Cross L, Nohata N, Ando M, Wahba A, Amornphimoltham P, Wu X, Gilardi M, Allevato M, Wu V, Steffen DJ, Tofilon P, Sonenberg N, Califano J, Chen Q, Lippman SM, Gutkind JS. PMID: 30894372; PMCID: PMC6445709.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    50. Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer. Cancer Res. 2019 02 15; 79(4):689-698. Murtuza A, Bulbul A, Shen JP, Keshavarzian P, Woodward BD, Lopez-Diaz FJ, Lippman SM, Husain H. PMID: 30718357.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    51. Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival. JCO Precis Oncol. 2019; 3. Kato S, Schwaederlé MC, Fanta PT, Okamura R, Leichman L, Lippman SM, Lanman RB, Raymond VM, Talasaz A, Kurzrock R. PMID: 31032472; PMCID: PMC6484865.
      View in: PubMed   Mentions: 30     Fields:    
    52. Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies. JCO Precis Oncol. 2019; 3. Kato S, Okamura R, Mareboina M, Lee S, Goodman A, Patel SP, Fanta PT, Schwab RB, Vu P, Raymond VM, Lanman RB, Sicklick JK, Lippman SM, Kurzrock R. PMID: 31058253; PMCID: PMC6497417.
      View in: PubMed   Mentions: 37     Fields:    
    53. APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy. Oncoimmunology. 2019; 8(3):1550341. Boichard A, Pham TV, Yeerna H, Goodman A, Tamayo P, Lippman S, Frampton GM, Tsigelny IF, Kurzrock R. PMID: 30723579; PMCID: PMC6350681.
      View in: PubMed   Mentions: 37     Fields:    
    54. AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health. Cancer Prev Res (Phila). 2018 12; 11(12):735-778. Lippman SM, Abate-Shen C, Colbert Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, Disis ML, DuBois RN, Szabo E, Giuliano AR, Hait WN, Lee JJ, Kensler TW, Kramer BS, Limburg P, Maitra A, Martinez ME, Rebbeck TR, Schmitz KH, Vilar E, Hawk ET. PMID: 30530635; PMCID: PMC10344465.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    55. Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clin Cancer Res. 2019 02 15; 25(4):1156-1164. Day TA, Shirai K, O'Brien PE, Matheus MG, Godwin K, Sood AJ, Kompelli A, Vick JA, Martin D, Vitale-Cross L, Callejas-Varela JL, Wang Z, Wu X, Harismendy O, Molinolo AA, Lippman SM, Van Waes C, Szabo E, Gutkind JS. PMID: 30420444; PMCID: PMC6377824.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    56. Intercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic Cancer. Pancreas. 2018 Nov/Dec; 47(10):1175-1176. Goggins MG, Lippman SM, Constantinou PE, Jacks T, Petersen GM, Syngal S, Maitra A. PMID: 30325853; PMCID: PMC6193263.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    57. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma. Clin Cancer Res. 2018 12 15; 24(24):6248-6256. Kato S, Okamura R, Baumgartner JM, Patel H, Leichman L, Kelly K, Sicklick JK, Fanta PT, Lippman SM, Kurzrock R. PMID: 30348637; PMCID: PMC6384095.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    58. Immunological and classical subtypes of oral premalignant lesions. Oncoimmunology. 2018; 7(12):e1496880. Foy JP, Bertolus C, Ortiz-Cuaran S, Albaret MA, Williams WN, Lang W, Destandau S, Souza G, Sohier E, Kielbassa J, Thomas E, Deneuve S, Goudot P, Puisieux A, Viari A, Mao L, Caux C, Lippman SM, Saintigny P. PMID: 30524889; PMCID: PMC6279331.
      View in: PubMed   Mentions: 19     Fields:    
    59. Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors. JAMA Oncol. 2018 09 01; 4(9):1237-1244. Goodman AM, Piccioni D, Kato S, Boichard A, Wang HY, Frampton G, Lippman SM, Connelly C, Fabrizio D, Miller V, Sicklick JK, Kurzrock R. PMID: 29902298; PMCID: PMC6139049.
      View in: PubMed   Mentions: 133     Fields:    Translation:Humans
    60. Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients. Sci Rep. 2018 Jul 13; 8(1):10640. Pierzynski JA, Ye Y, Lippman SM, Rodriguez MA, Wu X, Hildebrandt MAT. PMID: 30006595; PMCID: PMC6045646.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    61. Assembly and activation of the Hippo signalome by FAT1 tumor suppressor. Nat Commun. 2018 07 09; 9(1):2372. Martin D, Degese MS, Vitale-Cross L, Iglesias-Bartolome R, Valera JLC, Wang Z, Feng X, Yeerna H, Vadmal V, Moroishi T, Thorne RF, Zaida M, Siegele B, Cheong SC, Molinolo AA, Samuels Y, Tamayo P, Guan KL, Lippman SM, Lyons JG, Gutkind JS. PMID: 29985391; PMCID: PMC6037762.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    62. The Ashitaba (Angelica keiskei) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K. Cancer Prev Res (Phila). 2018 10; 11(10):607-620. Zhang T, Wang Q, Fredimoses M, Gao G, Wang K, Chen H, Wang T, Oi N, Zykova TA, Reddy K, Yao K, Ma W, Chang X, Lee MH, Rathore MG, Bode AM, Ashida H, Lippman SM, Dong Z. PMID: 29980517; PMCID: PMC6317334.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    63. Positive Surgical Margins in the 10 Most Common Solid Cancers. Sci Rep. 2018 04 09; 8(1):5686. Orosco RK, Tapia VJ, Califano JA, Clary B, Cohen EEW, Kane C, Lippman SM, Messer K, Molinolo A, Murphy JD, Pang J, Sacco A, Tringale KR, Wallace A, Nguyen QT. PMID: 29632347; PMCID: PMC5890246.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    64. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. J Natl Cancer Inst. 2018 03 01; 110(3). Saintigny P, William WN, Foy JP, Papadimitrakopoulou V, Lang W, Zhang L, Fan YH, Feng L, Kim ES, El-Naggar AK, Lee JJ, Mao L, Hong WK, Lingen MW, Lippman SM. PMID: 29617836; PMCID: PMC5946820.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    65. Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. Oncologist. 2018 05; 23(5):586-593. Ikeda S, Tsigelny IF, Skjevik ÅA, Kono Y, Mendler M, Kuo A, Sicklick JK, Heestand G, Banks KC, Talasaz A, Lanman RB, Lippman S, Kurzrock R. PMID: 29487225; PMCID: PMC5947459.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    66. Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer. Support Care Cancer. 2018 Jul; 26(7):2459-2469. Ha D, Ries AL, Mazzone PJ, Lippman SM, Fuster MM. PMID: 29429006; PMCID: PMC6110278.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    67. Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis. 2018 02 09; 39(2):125-133. Tang L, Platek ME, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Platz EA, Neuhouser ML, Stanczyk FZ, Reichardt JKV, Santella RM, Hsing A, Figg WD, Lippman SM, Thompson IM, Ambrosone CB. PMID: 29228205; PMCID: PMC6075364.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    68. Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma. Eur J Cancer. 2018 03; 92:20-32. Deng Y, Tu H, Pierzynski JA, Miller ED, Gu X, Huang M, Chang DW, Ye Y, Hildebrandt MAT, Klein AP, Zhao R, Lippman SM, Wu X. PMID: 29413686; PMCID: PMC7504973.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    69. Future cancer research priorities in the USA: a Lancet Oncology Commission. Lancet Oncol. 2017 11; 18(11):e653-e706. Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A. PMID: 29208398; PMCID: PMC6178838.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    70. Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single-arm phase II clinical trial. J Am Acad Dermatol. 2017 Dec; 77(6):1110-1113.e2. William WN, Feng L, Ferrarotto R, Ginsberg L, Kies M, Lippman S, Glisson B, Kim ES. PMID: 28964539; PMCID: PMC5685879.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCTClinical Trials
    71. A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts. Cancer Epidemiol Biomarkers Prev. 2017 10; 26(10):1549-1557. Platz EA, Kulac I, Barber JR, Drake CG, Joshu CE, Nelson WG, Lucia MS, Klein EA, Lippman SM, Parnes HL, Thompson IM, Goodman PJ, Tangen CM, De Marzo AM. PMID: 28754796; PMCID: PMC5626618.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    72. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017 08; 18(8):e457-e471. Kerr J, Anderson C, Lippman SM. PMID: 28759385; PMCID: PMC10441558.
      View in: PubMed   Mentions: 221     Fields:    Translation:Humans
    73. Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary. Cancer Res. 2017 08 15; 77(16):4238-4246. Kato S, Krishnamurthy N, Banks KC, De P, Williams K, Williams C, Leyland-Jones B, Lippman SM, Lanman RB, Kurzrock R. PMID: 28642281; PMCID: PMC5729906.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    74. Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology. Mol Cancer Ther. 2017 05; 16(5):948-955. Husain H, Nykin D, Bui N, Quan D, Gomez G, Woodward B, Venkatapathy S, Duttagupta R, Fung E, Lippman SM, Kurzrock R. PMID: 28468865.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    75. Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine. Clin Cancer Res. 2017 Aug 15; 23(16):4716-4723. Husain H, Melnikova VO, Kosco K, Woodward B, More S, Pingle SC, Weihe E, Park BH, Tewari M, Erlander MG, Cohen E, Lippman SM, Kurzrock R. PMID: 28420725; PMCID: PMC5737735.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    76. Precancer Atlas to Drive Precision Prevention Trials. Cancer Res. 2017 04 01; 77(7):1510-1541. Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M, Kay NE, Braggio E, Vilar E, Mazzilli SA, Rebbeck TR, Garber JE, Velculescu VE, Disis ML, Wallace DC, Lippman SM. PMID: 28373404; PMCID: PMC6681830.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansAnimalsCells
    77. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial. Prostate. 2017 Jun; 77(8):908-919. Winchester DA, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Xu J, Zheng SL, Thompson IM, Lucia MS, Lippman SM, Parnes HL, Isaacs WB, De Marzo AM, Drake CG, Platz EA. PMID: 28317149; PMCID: PMC5400704.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    78. Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer. J Oncol Pharm Pract. 2018 04; 24(3):229-231. Dasanu CA, Alvarez-Argote J, Lippman SM, Plaxe SC. PMID: 28436313.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    79. Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer. Cancer Discov. 2017 04; 7(4):410-423. Carter H, Marty R, Hofree M, Gross AM, Jensen J, Fisch KM, Wu X, DeBoever C, Van Nostrand EL, Song Y, Wheeler E, Kreisberg JF, Lippman SM, Yeo GW, Gutkind JS, Ideker T. PMID: 28188128; PMCID: PMC5460679.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    80. Translating Germline Cancer Risk into Precision Prevention. Cell. 2017 02 09; 168(4):566-570. Yurgelun MB, Chenevix-Trench G, Lippman SM. PMID: 28187278.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    81. Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma. Oral Oncol. 2017 02; 65:68-75. Krishnan AR, Korrapati A, Zou AE, Qu Y, Wang XQ, Califano JA, Wang-Rodriguez J, Lippman SM, Hovell MF, Ongkeko WM. PMID: 28109471; PMCID: PMC5291169.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    82. Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think Tank. Cancer Prev Res (Phila). 2017 Feb; 10(2):99-107. McCaskill-Stevens W, Pearson DC, Kramer BS, Ford LG, Lippman SM. PMID: 27965286; PMCID: PMC5292088.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    83. Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan. Sci Rep. 2016 11 02; 6:36482. Wu X, Wen CP, Ye Y, Tsai M, Wen C, Roth JA, Pu X, Chow WH, Huff C, Cunningham S, Huang M, Wu S, Tsao CK, Gu J, Lippman SM. PMID: 27805040; PMCID: PMC5090352.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    84. Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer. J Oncol Pharm Pract. 2017 Dec; 23(8):638-640. Dasanu CA, Lippman SM, Plaxe SC. PMID: 27824586.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    85. Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize. Nat Commun. 2016 10 04; 7:13019. Adams SR, Yang HC, Savariar EN, Aguilera J, Crisp JL, Jones KA, Whitney MA, Lippman SM, Cohen EE, Tsien RY, Advani SJ. PMID: 27698471; PMCID: PMC5059467.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    86. Leveraging premalignant biology for immune-based cancer prevention. Proc Natl Acad Sci U S A. 2016 09 27; 113(39):10750-8. Spira A, Disis ML, Schiller JT, Vilar E, Rebbeck TR, Bejar R, Ideker T, Arts J, Yurgelun MB, Mesirov JP, Rao A, Garber J, Jaffee EM, Lippman SM. PMID: 27638202; PMCID: PMC5047191.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    87. Sleep and Breathing … and Cancer? Cancer Prev Res (Phila). 2016 11; 9(11):821-827. Owens RL, Gold KA, Gozal D, Peppard PE, Jun JC, Dannenberg AJ, Lippman SM, Malhotra A, UCSD Sleep and Cancer Symposium Group. PMID: 27604751; PMCID: PMC5353979.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    88. The non-coding landscape of head and neck squamous cell carcinoma. Oncotarget. 2016 08 09; 7(32):51211-51222. Zou AE, Zheng H, Saad MA, Rahimy M, Ku J, Kuo SZ, Honda TK, Wang-Rodriguez J, Xuan Y, Korrapati A, Yu V, Singh P, Grandis JR, King CC, Lippman SM, Wang XQ, Hinton A, Ongkeko WM. PMID: 27323410; PMCID: PMC5239470.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    89. The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer. Oncotarget. 2016 Jun 14; 7(24):35932-35945. Foy JP, Tortereau A, Caulin C, Le Texier V, Lavergne E, Thomas E, Chabaud S, Perol D, Lachuer J, Lang W, Hong WK, Goudot P, Lippman SM, Bertolus C, Saintigny P. PMID: 27027432; PMCID: PMC5094973.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    90. Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer. Breast Cancer Res Treat. 2016 07; 158(1):67-77. Arun BK, Gong Y, Liu D, Litton JK, Gutierrez-Barrera AM, Jack Lee J, Vornik L, Ibrahim NK, Cornelison T, Hortobagyi GN, Heckman-Stoddard BM, Koenig KB, Alvarez RR, Murray JL, Valero V, Lippman SM, Brown P, Sneige N. PMID: 27287781; PMCID: PMC5989315.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    91. Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. EBioMedicine. 2016 May; 7:85-93. Kim J, Davis JW, Klein EA, Magi-Galluzzi C, Lotan Y, Ward JF, Pisters LL, Basler JW, Pettaway CA, Stephenson A, Li Ning Tapia EM, Efstathiou E, Wang X, Do KA, Lee JJ, Gorlov IP, Vornik LA, Hoque AM, Prokhorova IN, Parnes HL, Lippman SM, Thompson IM, Brown PH, Logothetis CJ, Troncoso P. PMID: 27322462; PMCID: PMC4909608.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    92. The Conundrum of Genetic "Drivers" in Benign Conditions. J Natl Cancer Inst. 2016 08; 108(8). Kato S, Lippman SM, Flaherty KT, Kurzrock R. PMID: 27059373; PMCID: PMC5017937.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    93. Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress. Free Radic Biol Med. 2016 06; 95:349-56. Guertin KA, Grant RK, Arnold KB, Burwell L, Hartline J, Goodman PJ, Minasian LM, Lippman SM, Klein E, Cassano PA. PMID: 27012420; PMCID: PMC4867301.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    94. A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers. Oncotarget. 2016 Mar 08; 7(10):10696-709. Yamaguchi K, Iglesias-Bartolomé R, Wang Z, Callejas-Valera JL, Amornphimoltham P, Molinolo AA, Cohen EE, Califano JA, Lippman SM, Luo J, Gutkind JS. PMID: 26882569; PMCID: PMC4905432.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    95. Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience. Mol Cancer Ther. 2016 04; 15(4):743-52. Schwaederle M, Parker BA, Schwab RB, Daniels GA, Piccioni DE, Kesari S, Helsten TL, Bazhenova LA, Romero J, Fanta PT, Lippman SM, Kurzrock R. PMID: 26873727.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    96. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16. William WN, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, Tang X, Kim ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar A, Lippman SM. PMID: 26540028; PMCID: PMC4771491.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    97. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial. Prostate. 2016 May; 76(6):565-74. Winchester DA, Gurel B, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Thompson IM, Xu J, Zheng SL, Lucia MS, Lippman SM, Parnes HL, Isaacs WB, Drake CG, De Marzo AM, Platz EA. PMID: 26771888; PMCID: PMC4841624.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    98. Catalyzing Cancer Prevention Research CaPR: A New Year/New Opportunities. Cancer Prev Res (Phila). 2016 Jan; 9(1):1. Lippman SM. PMID: 26744448.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    99. Transforming Cancer Prevention through Precision Medicine and Immune-oncology. Cancer Prev Res (Phila). 2016 Jan; 9(1):2-10. Kensler TW, Spira A, Garber JE, Szabo E, Lee JJ, Dong Z, Dannenberg AJ, Hait WN, Blackburn E, Davidson NE, Foti M, Lippman SM. PMID: 26744449; PMCID: PMC4955753.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimals
    100. Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2016 Mar; 25(3):463-9. Murtola TJ, Gurel B, Umbehr M, Lucia MS, Thompson IM, Goodman PJ, Kristal AR, Parnes HL, Lippman SM, Sutcliffe S, Peskoe SB, Barber JR, Drake CG, Nelson WG, De Marzo AM, Platz EA. PMID: 26715424; PMCID: PMC4779655.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    101. Cancer Prevention: Obstacles, Challenges and the Road Ahead. J Natl Cancer Inst. 2016 Feb; 108(2). Meyskens FL, Mukhtar H, Rock CL, Cuzick J, Kensler TW, Yang CS, Ramsey SD, Lippman SM, Alberts DS. PMID: 26547931; PMCID: PMC4907357.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsPHPublic Health
    102. Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology. Oncotarget. 2015 Oct 20; 6(32):32602-9. Patel SP, Schwaederle M, Daniels GA, Fanta PT, Schwab RB, Shimabukuro KA, Kesari S, Piccioni DE, Bazhenova LA, Helsten TL, Lippman SM, Parker BA, Kurzrock R. PMID: 26418953; PMCID: PMC4741715.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    103. Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus. Cancer Prev Res (Phila). 2015 Dec; 8(12):1131-7. Joe AK, Schnoll-Sussman F, Bresalier RS, Abrams JA, Hibshoosh H, Cheung K, Friedman RA, Yang CS, Milne GL, Liu DD, Lee JJ, Abdul K, Bigg M, Foreman J, Su T, Wang X, Ahmed A, Neugut AI, Akpa E, Lippman SM, Perloff M, Brown PH, Lightdale CJ. PMID: 26471236; PMCID: PMC4670789.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    104. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development. Cancer Prev Res (Phila). 2015 Nov; 8(11):1027-35. Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN, Frederick MJ, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar AK, Lee JJ, Myers JN, Issa JP, Lippman SM, Mao L, Saintigny P. PMID: 26342026; PMCID: PMC4777304.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    105. Molecular cancer prevention: Current status and future directions. CA Cancer J Clin. 2015 Sep-Oct; 65(5):345-83. Maresso KC, Tsai KY, Brown PH, Szabo E, Lippman S, Hawk ET. PMID: 26284997; PMCID: PMC4820069.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    106. Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1507-15. Nash SH, Till C, Song X, Lucia MS, Parnes HL, Thompson IM, Lippman SM, Platz EA, Schenk J. PMID: 26269564; PMCID: PMC4592455.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    107. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000. Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC, Bennett JM, Benz EJ, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA. PMID: 26211600; PMCID: PMC5365030.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    108. Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer. Oncotarget. 2015 Jun 30; 6(18):16746-56. Kim JS, Kim ES, Liu D, Lee JJ, Behrens C, Lippman SM, Hong WK, Wistuba II, Lee E, Lee HY. PMID: 25944691; PMCID: PMC4599304.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    109. The cancer cell map initiative: defining the hallmark networks of cancer. Mol Cell. 2015 May 21; 58(4):690-8. Krogan NJ, Lippman S, Agard DA, Ashworth A, Ideker T. PMID: 26000852; PMCID: PMC5359018.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    110. Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer. Prostate Cancer Prostatic Dis. 2015 Sep; 18(3):264-9. Umbehr MH, Gurel B, Murtola TJ, Sutcliffe S, Peskoe SB, Tangen CM, Goodman PJ, Thompson IM, Lippman SM, Lucia MS, Parnes HL, Drake CG, Nelson WG, De Marzo AM, Platz EA. PMID: 25939516; PMCID: PMC4537352.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    111. Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Prev Res (Phila). 2015 Jul; 8(7):590-6. Nash SH, Schenk JM, Kristal AR, Goodman PJ, Lucia MS, Parnes HL, Thompson IM, Lippman SM, Song X, Gurel B, De Marzo A, Platz EA. PMID: 25926387; PMCID: PMC4491033.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    112. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. Prostate. 2015 Aug 01; 75(11):1160-6. Heaphy CM, Gaonkar G, Peskoe SB, Joshu CE, De Marzo AM, Lucia MS, Goodman PJ, Lippman SM, Thompson IM, Platz EA, Meeker AK. PMID: 25893825; PMCID: PMC4475463.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    113. A randomized controlled trial of vitamin E and selenium on rate of decline in lung function. Respir Res. 2015 Mar 11; 16:35. Cassano PA, Guertin KA, Kristal AR, Ritchie KE, Bertoia ML, Arnold KB, Crowley JJ, Hartline J, Goodman PJ, Tangen CM, Minasian LM, Lippman SM, Klein E. PMID: 25889509; PMCID: PMC4404242.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    114. Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease. Urology. 2015 Mar; 85(3):616-20. Hoque A, Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, vanBokhoven A, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman SM, Ambrosone CB, Thompson IM. PMID: 25733274; PMCID: PMC4348556.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    115. Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma. Oral Oncol. 2015 May; 51(5):470-5. Raju SC, Hauff SJ, Lemieux AJ, Orosco RK, Gross AM, Nguyen LT, Savariar E, Moss W, Whitney M, Cohen EE, Lippman SM, Tsien RY, Ideker T, Advani SJ, Nguyen QT. PMID: 25735654; PMCID: PMC4427339.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    116. Telomere length and recurrence risk after curative resection in patients with early-stage non-small-cell lung cancer: a prospective cohort study. J Thorac Oncol. 2015 Feb; 10(2):302-8. Kim ES, Ye Y, Vaporciyan AA, Xing J, Huang M, Gu J, Roth JA, Lippman SM, Wu X. PMID: 25299235; PMCID: PMC4305022.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    117. Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial. JAMA Ophthalmol. 2015 Jan; 133(1):17-24. Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM, Blanke CD, Klein EA. PMID: 25232809; PMCID: PMC4395006.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    118. The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clin Cancer Res. 2015 Jan 01; 21(1):193-200. Wen CP, Zhang F, Liang D, Wen C, Gu J, Skinner H, Chow WH, Ye Y, Pu X, Hildebrandt MA, Huang M, Chen CH, Hsiung CA, Tsai MK, Tsao CK, Lippman SM, Wu X. PMID: 25336700; PMCID: PMC4286447.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    119. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res. 2014 Dec 15; 20(24):6570-81. Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK. PMID: 25316813; PMCID: PMC4268116.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    120. Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors. Clin Cancer Res. 2015 Feb 15; 21(4):693-700. Jones RL, Kim ES, Nava-Parada P, Alam S, Johnson FM, Stephens AW, Simantov R, Poondru S, Gedrich R, Lippman SM, Kaye SB, Carden CP. PMID: 25208878.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    121. Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):612-8. Hauff SJ, Raju SC, Orosco RK, Gross AM, Diaz-Perez JA, Savariar E, Nashi N, Hasselman J, Whitney M, Myers JN, Lippman SM, Tsien RY, Ideker T, Nguyen QT. PMID: 25091190; PMCID: PMC4469264.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    122. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nat Genet. 2014 Sep; 46(9):939-43. Gross AM, Orosco RK, Shen JP, Egloff AM, Carter H, Hofree M, Choueiri M, Coffey CS, Lippman SM, Hayes DN, Cohen EE, Grandis JR, Nguyen QT, Ideker T. PMID: 25086664; PMCID: PMC4146706.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    123. Molecular tumor board: the University of California-San Diego Moores Cancer Center experience. Oncologist. 2014 Jun; 19(6):631-6. Schwaederle M, Parker BA, Schwab RB, Fanta PT, Boles SG, Daniels GA, Bazhenova LA, Subramanian R, Coutinho AC, Ojeda-Fournier H, Datnow B, Webster NJ, Lippman SM, Kurzrock R. PMID: 24797821; PMCID: PMC4041669.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    124. Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy. Clin Pharmacol Ther. 2014 Sep; 96(3):360-369. Pu X, Hildebrandt MA, Lu C, Roth JA, Stewart DJ, Zhao Y, Heist RS, Ye Y, Chang DW, Su L, Minna JD, Lippman SM, Spitz MR, Christiani DC, Wu X. PMID: 24755914; PMCID: PMC4141040.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    125. An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nat Cell Biol. 2014 May; 16(5):457-68. Seguin L, Kato S, Franovic A, Camargo MF, Lesperance J, Elliott KC, Yebra M, Mielgo A, Lowy AM, Husain H, Cascone T, Diao L, Wang J, Wistuba II, Heymach JV, Lippman SM, Desgrosellier JS, Anand S, Weis SM, Cheresh DA. PMID: 24747441; PMCID: PMC4105198.
      View in: PubMed   Mentions: 209     Fields:    Translation:HumansAnimalsCells
    126. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):847-56. Gurel B, Lucia MS, Thompson IM, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S, Peskoe SB, Drake CG, Nelson WG, De Marzo AM, Platz EA. PMID: 24748218; PMCID: PMC4012292.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    127. Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study. Carcinogenesis. 2014 Aug; 35(8):1760-4. He Y, Gong Y, Gu J, Lee JJ, Lippman SM, Wu X. PMID: 24743515; PMCID: PMC4123647.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    128. John A. Milner: in memoriam (1947-2013). Cancer Prev Res (Phila). 2014 Apr; 7(4):373-4. Greenwald P, Stoner G, Colburn N, Lippman SM. PMID: 24695271.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    129. Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. J Hum Nutr Diet. 2015 Jun; 28(3):272-82. Crew KD, Ho KA, Brown P, Greenlee H, Bevers TB, Arun B, Sneige N, Hudis C, McArthur HL, Chang J, Rimawi M, Cornelison TL, Cardelli J, Santella RM, Wang A, Lippman SM, Hershman DL. PMID: 24646362; PMCID: PMC4205214.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    130. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst. 2014 Mar; 106(3):djt456. Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA. PMID: 24563519; PMCID: PMC3975165.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    131. Letter from the Editor. Cancer Prev Res (Phila). 2014 Feb; 7(2):179-81. Lippman SM. PMID: 24464731.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    132. Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer. Clin Lung Cancer. 2014 May; 15(3):213-21. Kim JS, Kim ES, Liu D, Lee JJ, Solis L, Behrens C, Lippman SM, Hong WK, Wistuba II, Lee HY. PMID: 24485233; PMCID: PMC4572464.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    133. Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial. Clin Cancer Res. 2013 Dec 15; 19(24):6967-75. Blumenschein GR, Saintigny P, Liu S, Kim ES, Tsao AS, Herbst RS, Alden C, Lee JJ, Tang X, Stewart DJ, Kies MS, Fossella FV, Tran HT, Mao L, Hicks ME, Erasmus J, Gupta S, Girard L, Peyton M, Diao L, Wang J, Davis SE, Minna JD, Wistuba I, Hong WK, Heymach JV, Lippman SM. PMID: 24166906; PMCID: PMC3905243.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    134. Human epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment. Head Neck. 2014 Mar; 36(3):E25-7. Falchook GS, Lippman SM, Bastida CC, Kurzrock R. PMID: 23852769; PMCID: PMC3893310.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    135. Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway. J Natl Cancer Inst. 2013 Oct 16; 105(20):1558-70. Shin DH, Lee HJ, Min HY, Choi SP, Lee MS, Lee JW, Johnson FM, Mehta K, Lippman SM, Glisson BS, Lee HY. PMID: 24092920; PMCID: PMC3797025.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    136. Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma. Cancer. 2013 Dec 15; 119(24):4277-83. Bau DT, Lippman SM, Xu E, Gong Y, Lee JJ, Wu X, Gu J. PMID: 24105340; PMCID: PMC3855186.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    137. Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. J Clin Oncol. 2013 Nov 20; 31(33):4179-87. Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston MR, Goodman G, Clamon G, Okawara G, Marks R, Frechette E, McCaskill-Stevens W, Lippman SM, Ruckdeschel J, Khuri FR. PMID: 24002495; PMCID: PMC3821010.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    138. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013 Aug 10; 31(23):2942-62. Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG, Wade JL, Lippman SM. PMID: 23835710.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    139. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PLoS One. 2013; 8(6):e66778. Mitani Y, Roberts DB, Fatani H, Weber RS, Kies MS, Lippman SM, El-Naggar AK. PMID: 23825564; PMCID: PMC3692530.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    140. Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Res. 2013 Aug 01; 73(15):4801-9. Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman SM, Ye Y, Minna JD, Wu X. PMID: 23774211; PMCID: PMC3760306.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    141. Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest. 2013 Jul; 123(7):2965-8. Stephens PJ, Davies HR, Mitani Y, Van Loo P, Shlien A, Tarpey PS, Papaemmanuil E, Cheverton A, Bignell GR, Butler AP, Gamble J, Gamble S, Hardy C, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, McLaren S, McBride DJ, Menzies A, Mudie L, Maddison M, Raine K, Nik-Zainal S, O'Meara S, Teague JW, Varela I, Wedge DC, Whitmore I, Lippman SM, McDermott U, Stratton MR, Campbell PJ, El-Naggar AK, Futreal PA. PMID: 23778141; PMCID: PMC3999050.
      View in: PubMed   Mentions: 126     Fields:    Translation:Humans
    142. Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers. Cancer Res. 2013 Jul 01; 73(13):4028-38. Wu X, Wang L, Ye Y, Aakre JA, Pu X, Chang GC, Yang PC, Roth JA, Marks RS, Lippman SM, Chang JY, Lu C, Deschamps C, Su WC, Wang WC, Huang MS, Chang DW, Li Y, Pankratz VS, Minna JD, Hong WK, Hildebrandt MA, Hsiung CA, Yang P. PMID: 23704207; PMCID: PMC3719971.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    143. Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trial. J Thorac Oncol. 2013 May; 8(5):658-61. Tsao AS, Liu S, Lee JJ, Alden CM, Blumenschein GR, Herbst R, Davis SE, Kim E, Lippman S, Heymach J, Tran H, Tang X, Wistuba I, Hong WK. PMID: 23584298; PMCID: PMC5118909.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    144. Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. Am J Pathol. 2013 Jun; 182(6):2048-57. Zhang L, Mitani Y, Caulin C, Rao PH, Kies MS, Saintigny P, Zhang N, Weber RS, Lippman SM, El-Naggar AK. PMID: 23583282; PMCID: PMC3668022.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    145. Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial. J Thorac Oncol. 2013 Apr; 8(4):436-42. Tam AL, Kim ES, Lee JJ, Ensor JE, Hicks ME, Tang X, Blumenschein GR, Alden CM, Erasmus JJ, Tsao A, Lippman SM, Hong WK, Wistuba II, Gupta S. PMID: 23442309; PMCID: PMC3879952.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    146. MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients. Cancer Res. 2013 Mar 15; 73(6):1867-75. Pu X, Roth JA, Hildebrandt MA, Ye Y, Wei H, Minna JD, Lippman SM, Wu X. PMID: 23378343; PMCID: PMC3602350.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    147. Natural-agent mechanisms and early-phase clinical development. Top Curr Chem. 2013; 329:241-52. Wang JL, Gold KA, Lippman SM. PMID: 22851156.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    148. Looking forward to 2013--saluting the exceptional year in 2012. Cancer Prev Res (Phila). 2013 Jan; 6(1):1-3. Lippman SM. PMID: 23282630.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    149. Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma. Am J Pathol. 2013 Feb; 182(2):529-39. Yan W, Shih J, Rodriguez-Canales J, Tangrea MA, Player A, Diao L, Hu N, Goldstein AM, Wang J, Taylor PR, Lippman SM, Wistuba II, Emmert-Buck MR, Erickson HS. PMID: 23219752; PMCID: PMC3562732.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    150. Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma. Arch Ophthalmol. 2012 Dec; 130(12):1608-11. El-Sawy T, Sabichi AL, Myers JN, Kies MS, William WN, Glisson BS, Lippman S, Esmaeli B. PMID: 23229707.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    151. CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma. Cancer Res. 2013 Jan 15; 73(2):571-82. Saintigny P, Massarelli E, Lin S, Ahn YH, Chen Y, Goswami S, Erez B, O'Reilly MS, Liu D, Lee JJ, Zhang L, Ping Y, Behrens C, Solis Soto LM, Heymach JV, Kim ES, Herbst RS, Lippman SM, Wistuba II, Hong WK, Kurie JM, Koo JS. PMID: 23204236; PMCID: PMC3548940.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansAnimalsCells
    152. Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial. J Thorac Oncol. 2012 Nov; 7(11):1645-52. Tsao AS, Liu S, Lee JJ, Alden C, Blumenschein G, Herbst R, Davis SE, Kim E, Lippman S, Stewart D, Tang XM, Wistuba I, Hong WK. PMID: 23059780; PMCID: PMC5161038.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    153. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res. 2013 Jan 01; 19(1):279-90. Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, Shen L, Fan Y, Giri U, Tumula PK, Nilsson MB, Gudikote J, Tran H, Cardnell RJ, Bearss DJ, Warner SL, Foulks JM, Kanner SB, Gandhi V, Krett N, Rosen ST, Kim ES, Herbst RS, Blumenschein GR, Lee JJ, Lippman SM, Ang KK, Mills GB, Hong WK, Weinstein JN, Wistuba II, Coombes KR, Minna JD, Heymach JV. PMID: 23091115; PMCID: PMC3567921.
      View in: PubMed   Mentions: 546     Fields:    Translation:HumansAnimalsCells
    154. Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study. Clin Cancer Res. 2012 Nov 01; 18(21):5983-91. Pu X, Ye Y, Spitz MR, Wang L, Gu J, Lippman SM, Hildebrandt MA, Hong WK, Minna JD, Roth JA, Yang P, Wu X. PMID: 22977190; PMCID: PMC3640870.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    155. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discov. 2012 Sep; 2(9):798-811. Byers LA, Wang J, Nilsson MB, Fujimoto J, Saintigny P, Yordy J, Giri U, Peyton M, Fan YH, Diao L, Masrorpour F, Shen L, Liu W, Duchemann B, Tumula P, Bhardwaj V, Welsh J, Weber S, Glisson BS, Kalhor N, Wistuba II, Girard L, Lippman SM, Mills GB, Coombes KR, Weinstein JN, Minna JD, Heymach JV. PMID: 22961666; PMCID: PMC3567922.
      View in: PubMed   Mentions: 257     Fields:    Translation:HumansCells
    156. Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride. Cancer Epidemiol Biomarkers Prev. 2012 Oct; 21(10):1823-32. Kristal AR, Till C, Tangen CM, Goodman PJ, Neuhouser ML, Stanczyk FZ, Chu LW, Patel SK, Thompson IM, Reichardt JK, Hoque A, Platz EA, Figg WD, Van Bokhoven A, Lippman SM, Hsing AW. PMID: 22879203; PMCID: PMC3467348.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    157. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer Prev Res (Phila). 2012 Sep; 5(9):1144-54. Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, McArthur HL, Chang J, Rimawi M, Vornik L, Cornelison TL, Wang A, Hibshoosh H, Ahmed A, Terry MB, Santella RM, Lippman SM, Hershman DL. PMID: 22827973; PMCID: PMC3816771.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCTClinical Trials
    158. Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion. Mol Cancer Ther. 2012 Sep; 11(9):2021-32. Saintigny P, Peng S, Zhang L, Sen B, Wistuba II, Lippman SM, Girard L, Minna JD, Heymach JV, Johnson FM. PMID: 22807579; PMCID: PMC3438283.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    159. Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk. Carcinogenesis. 2012 Sep; 33(9):1699-706. Lin J, Lu C, Stewart DJ, Gu J, Huang M, Chang DW, Lippman SM, Wu X. PMID: 22665367; PMCID: PMC3514904.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    160. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. Clin Cancer Res. 2012 Jul 01; 18(13):3705-13. Hildebrandt MA, Lippman SM, Etzel CJ, Kim E, Lee JJ, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. PMID: 22577058; PMCID: PMC3404728.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    161. Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors. Cancer. 2012 Aug 15; 118(16):3993-4003. Kim WY, Prudkin L, Feng L, Kim ES, Hennessy B, Lee JS, Lee JJ, Glisson B, Lippman SM, Wistuba II, Hong WK, Lee HY. PMID: 22359227; PMCID: PMC3674414.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    162. Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst. 2012 Feb 08; 104(3):228-39. Ihle NT, Byers LA, Kim ES, Saintigny P, Lee JJ, Blumenschein GR, Tsao A, Liu S, Larsen JE, Wang J, Diao L, Coombes KR, Chen L, Zhang S, Abdelmelek MF, Tang X, Papadimitrakopoulou V, Minna JD, Lippman SM, Hong WK, Herbst RS, Wistuba II, Heymach JV, Powis G. PMID: 22247021; PMCID: PMC3274509.
      View in: PubMed   Mentions: 240     Fields:    Translation:HumansCells
    163. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012 Jan; 16(1):103-19. Santarpia L, Lippman SM, El-Naggar AK. PMID: 22239440; PMCID: PMC3457779.
      View in: PubMed   Mentions: 395     Fields:    Translation:HumansAnimalsCells
    164. Letter from the editor. Cancer Prev Res (Phila). 2012 Jan; 5(1):1-2. Lippman SM. PMID: 22219161.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    165. An intermittent approach for cancer chemoprevention. Nat Rev Cancer. 2011 11 10; 11(12):879-85. Wu X, Lippman SM. PMID: 22071977.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    166. Aspirin and colorectal cancer prevention in Lynch syndrome. Lancet. 2011 Dec 17; 378(9809):2051-2. Chan AT, Lippman SM. PMID: 22036018; PMCID: PMC10344466.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    167. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12; 306(14):1549-56. Klein EA, Thompson IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL, Baker LH. PMID: 21990298; PMCID: PMC4169010.
      View in: PubMed   Mentions: 663     Fields:    Translation:Humans
    168. Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody. Mol Cancer Ther. 2011 Dec; 10(12):2437-48. Shin DH, Min HY, El-Naggar AK, Lippman SM, Glisson B, Lee HY. PMID: 21980128; PMCID: PMC3237768.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    169. Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011 Nov 15; 17(22):7003-14. Mitani Y, Rao PH, Futreal PA, Roberts DB, Stephens PJ, Zhao YJ, Zhang L, Mitani M, Weber RS, Lippman SM, Caulin C, El-Naggar AK. PMID: 21976542; PMCID: PMC3225955.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    170. Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. Carcinogenesis. 2011 Dec; 32(12):1867-71. Yin J, Lu C, Gu J, Lippman SM, Hildebrandt MA, Lin J, Stewart D, Spitz MR, Wu X. PMID: 21965272; PMCID: PMC3220611.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    171. Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer. Cancer. 2012 May 01; 118(9):2454-65. Kim JS, Kim ES, Liu D, Lee JJ, Solis L, Behrens C, Lippman SM, Hong WK, Wistuba II, Lee HY. PMID: 21952750; PMCID: PMC3298843.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    172. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila). 2011 Nov; 4(11):1761-9. Marshall JR, Tangen CM, Sakr WA, Wood DP, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, Davis W, Minasian LM, Thompson IM. PMID: 21896650; PMCID: PMC3208719.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    173. Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis. 2011 Oct; 32(10):1500-6. Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ, Reichardt JK, Santella RM, Hsing A, Hoque A, Lippman SM, Thompson IM, Ambrosone CB. PMID: 21771722; PMCID: PMC3179424.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    174. Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control. 2011 Aug; 22(8):1121-31. Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, Tang L, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman SM, Thompson IM, Ambrosone CB, Hoque A. PMID: 21667068; PMCID: PMC3139891.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    175. The BATTLE trial: personalizing therapy for lung cancer. Cancer Discov. 2011 Jun; 1(1):44-53. Kim ES, Herbst RS, Wistuba II, Lee JJ, Blumenschein GR, Tsao A, Stewart DJ, Hicks ME, Erasmus J, Gupta S, Alden CM, Liu S, Tang X, Khuri FR, Tran HT, Johnson BE, Heymach JV, Mao L, Fossella F, Kies MS, Papadimitrakopoulou V, Davis SE, Lippman SM, Hong WK. PMID: 22586319; PMCID: PMC4211116.
      View in: PubMed   Mentions: 360     Fields:    Translation:HumansCTClinical Trials
    176. Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events. Blood. 2011 Sep 01; 118(9):2622-31. Kim JH, Choi DS, Lee OH, Oh SH, Lippman SM, Lee HY. PMID: 21551235; PMCID: PMC3167363.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    177. Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer. Carcinogenesis. 2011 Jul; 32(7):1050-6. Lin M, Stewart DJ, Spitz MR, Hildebrandt MA, Lu C, Lin J, Gu J, Huang M, Lippman SM, Wu X. PMID: 21515830; PMCID: PMC3128559.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    178. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst. 2011 May 18; 103(10):817-25. Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, Roth JA, Minna JD, Gu J, Lin J, Buch SC, Nukui T, Ramirez Serrano JL, Taron M, Cassidy A, Lu C, Chang JY, Lippman SM, Hong WK, Spitz MR, Romkes M, Yang P. PMID: 21483023; PMCID: PMC3096796.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    179. The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival. Ann Oncol. 2012 Jan; 23(1):78-85. William WN, Kim JS, Liu DD, Solis L, Behrens C, Lee JJ, Lippman SM, Kim ES, Hong WK, Wistuba II, Lee HY. PMID: 21430184; PMCID: PMC3276321.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    180. Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules. Cancer Prev Res (Phila). 2011 Jan; 4(1):34-42. Veronesi G, Szabo E, Decensi A, Guerrieri-Gonzaga A, Bellomi M, Radice D, Ferretti S, Pelosi G, Lazzeroni M, Serrano D, Lippman SM, Spaggiari L, Nardi-Pantoli A, Harari S, Varricchio C, Bonanni B. PMID: 21163939; PMCID: PMC3017323.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    181. Transition of a clinical trial into translational research: the prostate cancer prevention trial experience. Cancer Prev Res (Phila). 2010 Dec; 3(12):1523-33. Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia MS, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML, Parnes HL, Reichardt JK, Santella RM, Till C, Lippman SM. PMID: 21149329; PMCID: PMC3058741.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    182. Phase II study of dasatinib in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2010 Oct 20; 28(30):4609-15. Johnson FM, Bekele BN, Feng L, Wistuba I, Tang XM, Tran HT, Erasmus JJ, Hwang LL, Takebe N, Blumenschein GR, Lippman SM, Stewart DJ. PMID: 20855820; PMCID: PMC2974341.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCellsCTClinical Trials
    183. MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. Carcinogenesis. 2010 Dec; 31(12):2118-23. Zhang X, Yang H, Lee JJ, Kim E, Lippman SM, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. PMID: 20819778; PMCID: PMC3105587.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    184. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One. 2010 Aug 25; 5(8):e12402. Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y, Lu C, Stewart DJ, Minna JD, Roth JA, Lippman SM, Cox JD, Hong WK, Spitz MR, Wu X. PMID: 20811626; PMCID: PMC2928273.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansPHPublic Health
    185. Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology. Contemp Clin Trials. 2010 Nov; 31(6):612-9. Lazzeroni M, Guerrieri-Gonzaga A, Serrano D, Varricchio MC, Veronesi G, Radice D, Feroce I, Nardi-Pantoli A, Lippman SM, Szabo E, Bonanni B. PMID: 20719253; PMCID: PMC2962433.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    186. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010 Oct 01; 16(19):4722-31. Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, Lippman SM, Weber RS, Caulin C, El-Naggar AK. PMID: 20702610; PMCID: PMC5862426.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    187. Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma. Carcinogenesis. 2010 Oct; 31(10):1755-61. Wang J, Lippman SM, Lee JJ, Yang H, Khuri FR, Kim E, Lin J, Chang DW, Lotan R, Hong WK, Wu X. PMID: 20627871; PMCID: PMC2950933.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    188. Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer. J Clin Oncol. 2010 Aug 01; 28(22):3611-6. Moinpour CM, Vaught NL, Goldman B, Redman MW, Philip PA, Millwood B, Lippman SM, Seay TE, Flynn PJ, O'Reilly EM, Rowland KM, Wong RP, Benedetti J, Blanke CD. PMID: 20606094; PMCID: PMC2917316.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    189. Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice. J Thorac Oncol. 2010 Jul; 5(7):940-9. Jacoby JJ, Erez B, Korshunova MV, Williams RR, Furutani K, Takahashi O, Kirkpatrick L, Lippman SM, Powis G, O'Reilly MS, Herbst RS. PMID: 20512076; PMCID: PMC3782111.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    190. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010 Jun 29; 2:15. Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS. PMID: 20587061; PMCID: PMC2908081.
      View in: PubMed   Mentions: 201     Fields:    Translation:HumansCells
    191. Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. Cancer Prev Res (Phila). 2010 Jul; 3(7):829-38. Shureiqi I, Chen D, Day RS, Zuo X, Hochman FL, Ross WA, Cole RA, Moy O, Morris JS, Xiao L, Newman RA, Yang P, Lippman SM. PMID: 20570882; PMCID: PMC2900425.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    192. Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer. Mol Cancer Ther. 2010 Jun; 9(6):1755-63. Byers LA, Holsinger FC, Kies MS, William WN, El-Naggar AK, Lee JJ, Hu J, Lopez A, Tran HT, Yan S, Du Z, Ang KK, Glisson BS, Raso MG, Wistuba II, Myers JN, Hong WK, Papadimitrakopoulou V, Lippman SM, Heymach JV. PMID: 20530716; PMCID: PMC2913168.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    193. Mortality in the randomized, controlled lung intergroup trial of isotretinoin. Cancer Prev Res (Phila). 2010 Jun; 3(6):738-44. Lee JJ, Feng L, Reshef DS, Sabichi AL, Williams B, Rinsurongkawong W, Wistuba II, Lotan R, Lippman SM. PMID: 20501862; PMCID: PMC2881192.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    194. Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer. Cancer. 2010 May 15; 116(10):2401-8. William WN, Kies MS, Fossella FV, Liu DD, Gladish G, Tse WH, Lee JJ, Hong WK, Lippman SM, Kim ES. PMID: 20225327; PMCID: PMC5145307.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    195. Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapy. Am J Clin Oncol. 2010 Apr; 33(2):148-52. William WN, Khuri FR, Fossella FV, Glisson BS, Zinner RG, Lee JJ, Herbst RS, Lippman SM, Kim ES. PMID: 19687727; PMCID: PMC5118944.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    196. Unprecedented opportunities and promise for cancer prevention research. Cancer Prev Res (Phila). 2010 Apr; 3(4):394-402. Blackburn EH, Tlsty TD, Lippman SM. PMID: 20354163.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    197. Prospective imaging assessment of mortality risk after head-and-neck radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):667-74. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. PMID: 20171802; PMCID: PMC3072063.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    198. Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog. 2010 Feb; 49(2):183-9. Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, Lee JJ, Wu X. PMID: 19851984; PMCID: PMC3640857.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    199. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74. Wang LE, Hu Z, Sturgis EM, Spitz MR, Strom SS, Amos CI, Guo Z, Qiao Y, Gillenwater AM, Myers JN, Clayman GL, Weber RS, El-Naggar AK, Mao L, Lippman SM, Hong WK, Wei Q. PMID: 20068090; PMCID: PMC2848391.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    200. Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies. Hum Mutat. 2010 Jan; 31(1):67-73. Musumeci L, Arthur JW, Cheung FS, Hoque A, Lippman S, Reichardt JK. PMID: 19877174; PMCID: PMC2797835.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    201. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010 Jan 01; 28(1):8-14. Kies MS, Holsinger FC, Lee JJ, William WN, Glisson BS, Lin HY, Lewin JS, Ginsberg LE, Gillaspy KA, Massarelli E, Byers L, Lippman SM, Hong WK, El-Naggar AK, Garden AS, Papadimitrakopoulou V. PMID: 19917840; PMCID: PMC2799235.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCellsCTClinical Trials
    202. Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients. Cancer Prev Res (Phila). 2009 Nov; 2(11):957-65. Kekatpure VD, Boyle JO, Zhou XK, Duffield-Lillico AJ, Gross ND, Lee NY, Subbaramaiah K, Morrow JD, Milne G, Lippman SM, Dannenberg AJ. PMID: 19843689; PMCID: PMC2784194.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    203. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res. 2009 Oct 01; 15(19):6284-91. Saintigny P, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim ES, Hong WK, Lippman SM, Mao L. PMID: 19773378; PMCID: PMC2756317.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    204. Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development. Cancer Res. 2009 Sep 15; 69(18):7439-48. Kim WY, Jin Q, Oh SH, Kim ES, Yang YJ, Lee DH, Feng L, Behrens C, Prudkin L, Miller YE, Lee JJ, Lippman SM, Hong WK, Wistuba II, Lee HY. PMID: 19738076; PMCID: PMC2745504.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimals
    205. Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience. Oncology. 2009; 77(2):75-81. Cox JD, Giralt SA, Veazie ML, Ajani JA, Bruner JM, Chan KW, Hittelman WN, Hunt KK, Iyer RB, Karp DD, Kuban DA, Lippman SM, Raad II, Rodriguez-Bigas MA, Zwelling LA, Markman M. PMID: 19571599; PMCID: PMC2790774.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    206. Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants. Cancer Prev Res (Phila). 2009 Jul; 2(7):617-24. Wu X, Spitz MR, Lee JJ, Lippman SM, Ye Y, Yang H, Khuri FR, Kim E, Gu J, Lotan R, Hong WK. PMID: 19584075; PMCID: PMC2964280.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    207. Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial. J Clin Oncol. 2009 Aug 01; 27(22):3569-72. Platz EA, Lippman SM. PMID: 19528369.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    208. Cancer prevention: from 1727 to milestones of the past 100 years. Cancer Res. 2009 Jul 01; 69(13):5269-84. Lippman SM, Hawk ET. PMID: 19491253.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    209. Cancer prevention research: back to the future. Cancer Prev Res (Phila). 2009 Jun; 2(6):503-13. Lippman SM. PMID: 19491288.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    210. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol. 2009 Jul 01; 27(19):3235-58. Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM, American Society of Clinical Oncology. PMID: 19470930; PMCID: PMC2716943.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    211. The changing face of phase 1 cancer clinical trials: new challenges in study requirements. Cancer. 2009 Apr 15; 115(8):1592-7. Craft BS, Kurzrock R, Lei X, Herbst R, Lippman S, Fu S, Karp DD. PMID: 19165808; PMCID: PMC2668727.
      View in: PubMed   Mentions: 8     Fields:    
    212. Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesions. Cancer. 2009 Apr 01; 115(7):1498-506. Pu X, Lippman SM, Yang H, Lee JJ, Wu X. PMID: 19197984; PMCID: PMC2666299.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    213. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol. 2009 May 20; 27(15):2509-15. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. PMID: 19332725; PMCID: PMC2739610.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCTClinical Trials
    214. Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data. Chest. 2009 Sep; 136(3):701-709. William WN, Lin HY, Lee JJ, Lippman SM, Roth JA, Kim ES. PMID: 19318668.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    215. Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells. Mol Cancer Ther. 2009 Mar; 8(3):521-32. Zinner RG, Barrett BL, Popova E, Damien P, Volgin AY, Gelovani JG, Lotan R, Tran HT, Pisano C, Mills GB, Mao L, Hong WK, Lippman SM, Miller JH. PMID: 19276160.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    216. Nutritional prevention of cancer: new directions for an increasingly complex challenge. J Natl Cancer Inst. 2009 Mar 18; 101(6):363-5. Kristal AR, Lippman SM. PMID: 19276449.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    217. Molecular targets for cancer chemoprevention. Nat Rev Drug Discov. 2009 Mar; 8(3):213-25. William WN, Heymach JV, Kim ES, Lippman SM. PMID: 19247304.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimals
    218. Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 04; 101(5):306-20. Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman SM, Logothetis CJ, Kim J. PMID: 19244175; PMCID: PMC2734116.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    219. Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors. Am J Clin Oncol. 2009 Feb; 32(1):15-9. William WN, Lee JL, Shin DM, Hong WK, Liu S, Lee JJ, Lippman SM, Khuri FR, Kim ES. PMID: 19194117; PMCID: PMC5120668.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    220. Cancer Prevention Research. Letter from the Editor. Cancer Prev Res (Phila). 2009 Jan; 2(1):1-2. Lippman SM. PMID: 19139009.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    221. High-dose fenretinide in oral leukoplakia. Cancer Prev Res (Phila). 2009 Jan; 2(1):22-6. William WN, Lee JJ, Lippman SM, Martin JW, Chakravarti N, Tran HT, Sabichi AL, Kim ES, Feng L, Lotan R, Papadimitrakopoulou VA. PMID: 19139014; PMCID: PMC4161148.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCellsCTClinical Trials
    222. Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res (Phila). 2009 Jan; 2(1):14-21. Papadimitrakopoulou V, Izzo JG, Liu DD, Myers J, Ceron TL, Lewin J, William WN, Atwell A, Lee JJ, Gillenwater A, El-Naggar A, Wu X, Lippman SM, Hittelman WN, Hong WK. PMID: 19139013; PMCID: PMC4243520.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    223. Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy. J Clin Oncol. 2009 Feb 01; 27(4):599-604. Papadimitrakopoulou VA, Lee JJ, William WN, Martin JW, Thomas M, Kim ES, Khuri FR, Shin DM, Feng L, Hong WK, Lippman SM. PMID: 19075276; PMCID: PMC2645856.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    224. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009 Jan 07; 301(1):39-51. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL, Baker LH, Coltman CA. PMID: 19066370; PMCID: PMC3682779.
      View in: PubMed   Mentions: 791     Fields:    Translation:HumansCTClinical Trials
    225. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest. 2008 Dec; 134(6):1349. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. PMID: 19059972.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    226. Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial. Lancet. 2008 Nov 22; 372(9652):1809-18. Kim ES, Hirsh V, Mok T, Socinski MA, Gervais R, Wu YL, Li LY, Watkins CL, Sellers MV, Lowe ES, Sun Y, Liao ML, Osterlind K, Reck M, Armour AA, Shepherd FA, Lippman SM, Douillard JY. PMID: 19027483.
      View in: PubMed   Mentions: 450     Fields:    Translation:HumansCTClinical Trials
    227. The future of molecular-targeted cancer chemoprevention. Gastroenterology. 2008 Dec; 135(6):1834-41. Lippman SM. PMID: 18996123.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    228. Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer. 2008 Nov 01; 113(9):2488-95. Ye Y, Lippman SM, Lee JJ, Chen M, Frazier ML, Spitz MR, Wu X. PMID: 18823025; PMCID: PMC2577230.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    229. Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goal. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):2903-5. Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM, CEBP Senior Editors and CaPR Deputy and Senior Editors. PMID: 18990728.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    230. Cancer epidemiology, biomarkers & prevention and cancer prevention research: two journals, a common goal. Cancer Prev Res (Phila). 2008 Nov; 1(6):393-5. Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM, CEBP Senior Editors and CaPR Deputy and Senior Editors. PMID: 19138984.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    231. Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. J Natl Cancer Inst. 2008 Oct 15; 100(20):1420-3. Howe LR, Lippman SM. PMID: 18840814; PMCID: PMC2567416.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    232. Lung cancer. N Engl J Med. 2008 Sep 25; 359(13):1367-80. Herbst RS, Heymach JV, Lippman SM. PMID: 18815398; PMCID: PMC10662965.
      View in: PubMed   Mentions: 1235     Fields:    Translation:HumansCells
    233. Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer. Cancer Res. 2008 Aug 01; 68(15):6065-73. Seo HS, Liu DD, Bekele BN, Kim MK, Pisters K, Lippman SM, Wistuba II, Koo JS. PMID: 18676828; PMCID: PMC3058903.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    234. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Eur J Cancer. 2008 Jul; 44(11):1603-11. Yang H, Lippman SM, Huang M, Jack Lee J, Wang W, Spitz MR, Wu X. PMID: 18579371; PMCID: PMC2603619.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    235. Inaugural issue of Cancer Prevention Research. Cancer Prev Res (Phila). 2008 Jun; 1(1):1-3. Lippman SM. PMID: 19138928.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    236. Does the level of prostate cancer risk affect cancer prevention with finasteride? Urology. 2008 May; 71(5):854-7. Thompson IM, Tangen CM, Parnes HL, Lippman SM, Coltman CA. PMID: 18455628; PMCID: PMC2692669.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    237. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer. 2008 May 01; 112(9):2088-100. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S, Ohshiro K, Rosenthal DI, Weber RS, Gallick GE, El-Naggar AK. PMID: 18327819.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    238. Pilot randomized phase II study of celecoxib in oral premalignant lesions. Clin Cancer Res. 2008 Apr 01; 14(7):2095-101. Papadimitrakopoulou VA, William WN, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO. PMID: 18381950.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    239. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. J Clin Oncol. 2008 Apr 01; 26(10):1650-6. Goodwin JW, Green SJ, Moinpour CM, Bearden JD, Giguere JK, Jiang CS, Lippman SM, Martino S, Albain KS. PMID: 18375894.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    240. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis. Cancer. 2008 Mar 01; 112(5):1058-65. Svatek RS, Lee JJ, Roehrborn CG, Lippman SM, Lotan Y. PMID: 18186497.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    241. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol. 2008 Jan 20; 26(3):354-60. Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim E, Hong WK, Lippman SM, Mao L. PMID: 18202409.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    242. 15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation. FASEB J. 2008 Jun; 22(6):1981-92. Zuo X, Shen L, Issa JP, Moy O, Morris JS, Lippman SM, Shureiqi I. PMID: 18198215; PMCID: PMC2410033.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    243. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9. Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM. PMID: 18172274.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    244. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res. 2007 Nov 01; 13(21):6532-9. Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, Guo Z, Qiao Y, Clayman GL, Lee JJ, El-Naggar AK, Prieto VG, Duvic M, Lippman SM, Weber RS, Kripke ML, Wei Q. PMID: 17975167.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    245. Meeting Report: Fifth Annual AACR Frontiers in Cancer Prevention Research. Cancer Res. 2007 Oct 01; 67(19):8989-93. Hoque A, Parnes HL, Stefanek ME, Heymach JV, Brown PH, Lippman SM. PMID: 17895292.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    246. Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2007 Sep 19; 99(18):1375-83. Lucia MS, Epstein JI, Goodman PJ, Darke AK, Reuter VE, Civantos F, Tangen CM, Parnes HL, Lippman SM, La Rosa FG, Kattan MW, Crawford ED, Ford LG, Coltman CA, Thompson IM. PMID: 17848673.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    247. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial. J Clin Oncol. 2007 Jul 20; 25(21):3076-81. Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA. PMID: 17634486.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    248. The convergent development of molecular-targeted drugs for cancer treatment and prevention. Clin Cancer Res. 2007 Jul 15; 13(14):4035-41. Lippman SM, Heymach JV. PMID: 17634526.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    249. Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2007 Jul 04; 99(13):1025-35. Moinpour CM, Darke AK, Donaldson GW, Thompson IM, Langley C, Ankerst DP, Patrick DL, Ware JE, Ganz PA, Shumaker SA, Lippman SM, Coltman CA. PMID: 17596576.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    250. Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res. 2007 Jun 15; 13(12):3753-8. Wang Y, Spitz MR, Lee JJ, Huang M, Lippman SM, Wu X. PMID: 17575242.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    251. Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence. J Clin Oncol. 2007 May 20; 25(15):2093-9. Gotay CC, Moinpour CM, Unger JM, Jiang CS, Coleman D, Martino S, Parker BJ, Bearden JD, Dakhil S, Gross HM, Lippman S, Albain KS. PMID: 17513815.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    252. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol. 2007 May 20; 25(15):1974-8. Brewster AM, Lee JJ, Clayman GL, Clifford JL, Reyes MJ, Zhou X, Sabichi AL, Strom SS, Collins R, Meyers CA, Lippman SM. PMID: 17513803.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    253. Finasteride decreases the risk of prostatic intraepithelial neoplasia. J Urol. 2007 Jul; 178(1):107-9; discussion 110. Thompson IM, Lucia MS, Redman MW, Darke A, La Rosa FG, Parnes HL, Lippman SM, Coltman CA. PMID: 17499284.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    254. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection. J Urol. 2007 May; 177(5):1749-52. Thompson IM, Tangen CM, Goodman PJ, Lucia MS, Parnes HL, Lippman SM, Coltman CA. PMID: 17437804.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    255. Molecular signatures of lung cancer--toward personalized therapy. N Engl J Med. 2007 Jan 04; 356(1):76-8. Herbst RS, Lippman SM. PMID: 17202459.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    256. The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. FASEB J. 2007 Mar; 21(3):743-53. Shureiqi I, Zuo X, Broaddus R, Wu Y, Guan B, Morris JS, Lippman SM. PMID: 17167069; PMCID: PMC1847772.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    257. Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need. Cancer Res. 2006 Dec 15; 66(24):11540-9. Herberman RB, Pearce HL, Lippman SM, Pyenson BS, Alberts DS. PMID: 17158189.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    258. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1977-83. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Lippman SM, Platz EA, Pollak MN, Thompson IM, Kristal AR. PMID: 17035408.
      View in: PubMed   Mentions: 131     Fields:    Translation:Humans
    259. The dilemma and promise of cancer chemoprevention. Nat Clin Pract Oncol. 2006 Oct; 3(10):523. Lippman SM. PMID: 17019426.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    260. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. J Natl Cancer Inst. 2006 Aug 16; 98(16):1128-33. Thompson IM, Chi C, Ankerst DP, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA. PMID: 16912265.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    261. The cost of prostate cancer chemoprevention: a decision analysis model. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1485-9. Svatek RS, Lee JJ, Roehrborn CG, Lippman SM, Lotan Y. PMID: 16896037.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    262. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1479-84. Marshall JR, Sakr W, Wood D, Berry D, Tangen C, Parker F, Thompson I, Lippman SM, Lieberman R, Alberts D, Jarrard D, Coltman C, Greenwald P, Minasian L, Crawford ED. PMID: 16896036.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    263. RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA. Cancer Res. 2006 Jul 15; 66(14):7111-8. Liang ZD, Lippman SM, Wu TT, Lotan R, Xu XC. PMID: 16849557.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    264. 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis. J Invest Dermatol. 2007 Jan; 127(1):196-205. Wang LE, Hsu TC, Xiong P, Strom SS, Duvic M, Clayman GL, Weber RS, Lippman SM, Goldberg LH, Wei Q. PMID: 16841033.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    265. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res. 2006 Jun 15; 12(12):3661-97. Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK, AACR Task Force on Cancer Prevention. PMID: 16778094.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCells
    266. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006 Jun 21; 295(23):2727-41. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N, National Surgical Adjuvant Breast and Bowel Project (NSABP). PMID: 16754727.
      View in: PubMed   Mentions: 480     Fields:    Translation:Humans
    267. The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members. J Clin Oncol. 2006 Jun 20; 24(18):2948-57. American Society of Clinical Oncology, Ganz PA, Kwan L, Somerfield MR, Alberts D, Garber JE, Offit K, Lippman SM. PMID: 16702579.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    268. Fenretinide activity in retinoid-resistant oral leukoplakia. Clin Cancer Res. 2006 May 15; 12(10):3109-14. Lippman SM, Lee JJ, Martin JW, El-Naggar AK, Xu X, Shin DM, Thomas M, Mao L, Fritsche HA, Zhou X, Papadimitrakopoulou V, Khuri FR, Tran H, Clayman GL, Hittelman WN, Hong WK, Lotan R. PMID: 16707609.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    269. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma. Oncogene. 2006 Sep 28; 25(44):6015-25. Subbarayan V, Krieg P, Hsi LC, Kim J, Yang P, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman SM, Menter DG. PMID: 16682954.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    270. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis. 2006 Oct; 27(10):2034-7. Huang M, Spitz MR, Gu J, Lee JJ, Lin J, Lippman SM, Wu X. PMID: 16638786.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    271. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 2006 Apr 05; 98(7):441-50. Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, Winn R, Pajak TF, Williams B, Shenouda G, Hodson I, Fu K, Shin DM, Vokes EE, Feng L, Goepfert H, Hong WK. PMID: 16595780.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCTClinical Trials
    272. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2178-84. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, Minasian LM, Pisters LL, Caton JR, Basler JW, Lerner SP, Menter DG, Marshall JR, Crawford ED, Lippman SM. PMID: 16609032.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    273. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. Cancer Res. 2006 Mar 15; 66(6):2893-903. Lippman SM, Lee JJ. PMID: 16540634.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    274. Identification and characterization of the human retinoid X receptor alpha gene promoter. Gene. 2006 May 10; 372:118-27. Li G, Yin W, Chamberlain R, Hewett-Emmett D, Roberts JN, Yang X, Lippman SM, Clifford JL. PMID: 16517099.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    275. Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene. 2006 Feb 23; 25(8):1225-41. Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM, Lippman SM, Shureiqi I. PMID: 16288226; PMCID: PMC1432095.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    276. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31. Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, Ross MI, Mansfield PF, Gershenwald JE, Prieto VG, Cormier JN, Duvic M, Clayman GL, Weber RS, Lippman SM, Amos CI, Spitz MR, Wei Q. PMID: 16368944.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    277. The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res. 2005 Dec 15; 65(24):11486-92. Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS, Yang P, Newman RA, Broaddus R, Hamilton SR, Lynch P, Levin B, Fischer SM, Lippman SM. PMID: 16357157; PMCID: PMC1564070.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    278. Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression. Oncogene. 2005 Dec 15; 24(56):8268-76. Song S, Lippman SM, Zou Y, Ye X, Ajani JA, Xu XC. PMID: 16170369.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    279. Statins and cancer prevention. Nat Rev Cancer. 2005 Dec; 5(12):930-42. Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. PMID: 16341084.
      View in: PubMed   Mentions: 326     Fields:    Translation:HumansAnimals
    280. RARbeta1': primed to fight retinoid resistance in lung carcinogenesis. J Natl Cancer Inst. 2005 Nov 16; 97(22):1632-3. Sabichi AL, Xu X, Lippman SM. PMID: 16288110.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    281. Phase III prostate cancer prevention trials: are the costs justified? J Clin Oncol. 2005 Nov 10; 23(32):8161-4. Thompson IM, Tangen CM, Klein EA, Lippman SM. PMID: 16278467.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    282. The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Mol Cancer Ther. 2005 Nov; 4(11):1740-6. Hsi LC, Xi X, Wu Y, Lippman SM. PMID: 16275995.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    283. Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study. Lancet. 2005 Oct 15-21; 366(9494):1359-66. Sudbø J, Lee JJ, Lippman SM, Mork J, Sagen S, Flatner N, Ristimäki A, Sudbø A, Mao L, Zhou X, Kildal W, Evensen JF, Reith A, Dannenberg AJ. PMID: 16226613.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    284. Cigarettes: a smoking gun in cancer chemoprevention. J Natl Cancer Inst. 2005 Sep 21; 97(18):1319-21. Mayne ST, Lippman SM. PMID: 16174848.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    285. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells. Cancer Res. 2005 Sep 15; 65(18):8442-7. Deguchi A, Xing SW, Shureiqi I, Yang P, Newman RA, Lippman SM, Feinmark SJ, Oehlen B, Weinstein IB. PMID: 16166323.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    286. Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited. J Clin Oncol. 2005 Oct 20; 23(30):7460-6. Klein EA, Tangen CM, Goodman PJ, Lippman SM, Thompson IM. PMID: 16157937.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    287. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005 Sep; 115(9):1561-7. Moore BA, Weber RS, Prieto V, El-Naggar A, Holsinger FC, Zhou X, Lee JJ, Lippman S, Clayman GL. PMID: 16148695.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    288. Combined targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways. Clin Cancer Res. 2005 Sep 01; 11(17):6097-9. Lippman SM, Gibson N, Subbaramaiah K, Dannenberg AJ. PMID: 16144906.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    289. Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products. Cancer Res. 2005 Jul 15; 65(14):6189-98. Kim J, Yang P, Suraokar M, Sabichi AL, Llansa ND, Mendoza G, Subbarayan V, Logothetis CJ, Newman RA, Lippman SM, Menter DG. PMID: 16024620.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    290. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1697-702. Kim J, Sun P, Lam YW, Troncoso P, Sabichi AL, Babaian RJ, Pisters LL, Pettaway CA, Wood CG, Lippman SM, McDonnell TJ, Lieberman R, Logothetis C, Ho SM. PMID: 16030104.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    291. Advances in the biology of lung cancer chemoprevention. J Clin Oncol. 2005 May 10; 23(14):3186-97. Hirsch FR, Lippman SM. PMID: 15886305.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    292. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol. 2005 May 01; 23(13):2900-2. Ewer MS, Lippman SM. PMID: 15860848.
      View in: PubMed   Mentions: 188     Fields:    Translation:Humans
    293. Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):826-9. Xu XC, Lee JJ, Wu TT, Hoque A, Ajani JA, Lippman SM. PMID: 15824151.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    294. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis. 2005 Aug; 26(8):1368-73. Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, Langlois M, Chan JM, Yuan J, Harris CC, Bowman ED, Clayman GL, Lippman SM, Lee JJ, Zheng W, Balmain A. PMID: 15802297.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimals
    295. Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes. J Clin Oncol. 2005 Mar 20; 23(9):1911-20. Lotan Y, Cadeddu JA, Lee JJ, Roehrborn CG, Lippman SM. PMID: 15774783.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    296. Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia. Neoplasia. 2005 Mar; 7(3):280-93. Subbarayan V, Xu XC, Kim J, Yang P, Hoque A, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman SM, Menter DG. PMID: 15799828; PMCID: PMC1501140.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    297. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005 Feb 01; 23(4):759-65. Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK, Prieto VG, Altamirano E, Tucker SL, Strom SS, Kripke ML, Lippman SM. PMID: 15681519.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    298. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis. 2005 Apr; 26(4):785-91. Hoque A, Lippman SM, Wu TT, Xu Y, Liang ZD, Swisher S, Zhang H, Cao L, Ajani JA, Xu XC. PMID: 15661803.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    299. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005 Jan 19; 97(2):94-102. Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA. PMID: 15657339.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    300. Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol. 2005 Jan 10; 23(2):346-56. Lippman SM, Sudbø J, Hong WK. PMID: 15637397.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    301. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol. 2005 Jan 10; 23(2):254-66. Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, DuBois RN. PMID: 15637389.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansCells
    302. Cancer prevention: strong science and real medicine. J Clin Oncol. 2005 Jan 10; 23(2):249-53. Lippman SM, Levin B. PMID: 15637388.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    303. Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Clin Trials. 2005; 2(5):436-42. Cook ED, Moody-Thomas S, Anderson KB, Campbell R, Hamilton SJ, Harrington JM, Lippman SM, Minasian LM, Paskett ED, Craine S, Arnold KB, Probstfield JL. PMID: 16315648.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    304. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Cancer Res. 2004 Dec 01; 64(23):8778-81. Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM. PMID: 15574791.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    305. Can selenium prevent colorectal cancer? A signpost from epidemiology. J Natl Cancer Inst. 2004 Nov 17; 96(22):1645-7. Duffield-Lillico AJ, Shureiqi I, Lippman SM. PMID: 15547171.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    306. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1704-9. Sabichi AL, Subbarayan V, Llansa N, Lippman SM, Menter DG. PMID: 15533896.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    307. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1710-6. Subbarayan V, Sabichi AL, Kim J, Llansa N, Logothetis CJ, Lippman SM, Menter DG. PMID: 15533897.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    308. The convergence of cancer prevention and therapy in early-phase clinical drug development. Cancer Cell. 2004 Oct; 6(4):321-6. Abbruzzese JL, Lippman SM. PMID: 15488755.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    309. Cancer prevention and the American Society of Clinical Oncology. J Clin Oncol. 2004 Oct 01; 22(19):3848-51. Lippman SM, Levin B, Brenner DE, Gordon GB, Aldige CR, Kramer BS, Garber JE, Hawk E, Ganz PA, Somerfield MR, Writing Committee of the ASCO Cancer Prevention Committee. PMID: 15353541.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    310. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med. 2004 May 27; 350(22):2239-46. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA. PMID: 15163773.
      View in: PubMed   Mentions: 644     Fields:    Translation:HumansCTClinical Trials
    311. Science peels the onion of selenium effects on prostate carcinogenesis. J Natl Cancer Inst. 2004 May 05; 96(9):645-7. Taylor PR, Parnes HL, Lippman SM. PMID: 15126594.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    312. COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer. Semin Oncol. 2004 Apr; 31(2 Suppl 7):36-44. Sabichi AL, Lippman SM. PMID: 15179622.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    313. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ. Int J Oncol. 2004 Apr; 24(4):879-84. Liu J, Baykal A, Fung KM, Thompson-Lanza JA, Hoque A, Lippman SM, Sahin A. PMID: 15010825.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    314. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med. 2004 Apr 01; 350(14):1405-13. Sudbø J, Lippman SM, Lee JJ, Mao L, Kildal W, Sudbø A, Sagen S, Bryne M, El-Naggar A, Risberg B, Evensen JF, Reith A. PMID: 15070790.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    315. Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res. 2004 Mar 01; 10(5):1733-42. Youssef EM, Lotan D, Issa JP, Wakasa K, Fan YH, Mao L, Hassan K, Feng L, Lee JJ, Lippman SM, Hong WK, Lotan R. PMID: 15014026.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    316. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res. 2004 Mar 01; 10(5):1565-73. Mulshine JL, Atkinson JC, Greer RO, Papadimitrakopoulou VA, Van Waes C, Rudy S, Martin JW, Steinberg SM, Liewehr DJ, Avis I, Linnoila RI, Hewitt S, Lippman SM, Frye R, Cavanaugh PF. PMID: 15014005.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    317. Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity. J Biol Chem. 2004 Apr 30; 279(18):19191-200. Salas TR, Kim J, Vakar-Lopez F, Sabichi AL, Troncoso P, Jenster G, Kikuchi A, Chen SY, Shemshedini L, Suraokar M, Logothetis CJ, DiGiovanni J, Lippman SM, Menter DG. PMID: 14985354.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    318. Prevention of prostate cancer with finasteride: US/European perspective. Eur Urol. 2003 Dec; 44(6):650-5. Thompson IM, Klein EA, Lippman SM, Coltman CA, Djavan B. PMID: 14644115.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    319. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev. 2003 Dec; 12(12):1518-22. Hoque A, Carter J, Xia W, Hung MC, Sahin AA, Sen S, Lippman SM. PMID: 14693746.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    320. Molecular based treatment of oral cancer. Oral Oncol. 2003 Dec; 39(8):749-58. Sudbø J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Søland TM, Lippman SM. PMID: 13679198.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    321. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma. Cancer. 2003 Nov 15; 98(10):2214-23. Papadimitrakopoulou VA, Ginsberg LE, Garden AS, Kies MS, Glisson BS, Diaz EM, Clayman G, Morrison WH, Liu DD, Blumenschein G, Lippman SM, Schommer D, Gillenwater A, Goepfert H, Hong WK. PMID: 14601092.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    322. An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J Clin Oncol. 2003 Dec 15; 21(24):4546-52. Rudin CM, Cohen EE, Papadimitrakopoulou VA, Silverman S, Recant W, El-Naggar AK, Stenson K, Lippman SM, Hong WK, Vokes EE. PMID: 14597742; PMCID: PMC4523388.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCellsCTClinical Trials
    323. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003 Oct; 76(4):1001-7; discussion 1007-8. Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, Vaporciyan A, Smythe WR, Swisher S, Walsh G, Putnam JB, Hong WK, Roth J. PMID: 14529975.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    324. Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study. Ann Surg Oncol. 2003 Oct; 10(8):870-5. Chu DZ, Chansky K, Alberts DS, Meyskens FL, Fenoglio-Preiser CM, Rivkin SE, Mills GM, Giguere JK, Goodman GE, Abbruzzese JL, Lippman SM. PMID: 14527904.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    325. Centrosomal abnormality is common in and a potential biomarker for bladder cancer. Int J Cancer. 2003 Sep 20; 106(5):661-5. Jiang F, Caraway NP, Sabichi AL, Zhang HZ, Ruitrok A, Grossman HB, Gu J, Lerner SP, Lippman S, Katz RL. PMID: 12866024.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    326. Frontiers in cancer prevention research. Cancer Res. 2003 Sep 15; 63(18):5649-55. Sabichi AL, Demierre MF, Hawk ET, Lerman CE, Lippman SM. PMID: 14522879.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    327. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 1):3660-6. Wang L, Hoque A, Luo RZ, Yuan J, Lu Z, Nishimoto A, Liu J, Sahin AA, Lippman SM, Bast RC, Yu Y. PMID: 14506155.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    328. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9968-73. Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM, Lippman SM. PMID: 12909723; PMCID: PMC187904.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansAnimalsCells
    329. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei. J Biol Chem. 2003 Oct 17; 278(42):41338-46. Salas TR, Reddy SA, Clifford JL, Davis RJ, Kikuchi A, Lippman SM, Menter DG. PMID: 12900420.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    330. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide. Clin Cancer Res. 2003 Jul; 9(7):2400-5. Sabichi AL, Modiano MR, Lee JJ, Peng YM, Xu MJ, Villar H, Dalton WS, Lippman SM. PMID: 12855611.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    331. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003 Jul 17; 349(3):215-24. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA. PMID: 12824459.
      View in: PubMed   Mentions: 721     Fields:    Translation:HumansCTClinical Trials
    332. Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells. Mol Cancer Ther. 2003 May; 2(5):453-9. Clifford JL, Yang X, Walch E, Wang M, Lippman SM. PMID: 12748307.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    333. Identification of benzo(a)pyrene diol epoxide-binding DNA fragments using DNA immunoprecipitation technique. Cancer Res. 2003 Apr 01; 63(7):1470-4. Liang Z, Lippman SM, Kawabe A, Shimada Y, Xu XC. PMID: 12670892.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    334. The selenium and vitamin E cancer prevention trial. World J Urol. 2003 May; 21(1):21-7. Klein EA, Lippman SM, Thompson IM, Goodman PJ, Albanes D, Taylor PR, Coltman C. PMID: 12756490.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    335. Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398. Neoplasia. 2003 Mar-Apr; 5(2):121-7. Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V, Iyengar S, Tang DG, Lippman SM. PMID: 12659684; PMCID: PMC1502398.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    336. SELECT: the selenium and vitamin E cancer prevention trial. Urol Oncol. 2003 Jan-Feb; 21(1):59-65. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C. PMID: 12684129.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    337. COX-2 inhibitors and other NSAIDs in bladder and prostate cancer. Prog Exp Tumor Res. 2003; 37:163-78. Sabichi AL, Lippman SM. PMID: 12795054.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    338. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res. 2003 Jan; 9(1):228-34. Bolshakov S, Walker CM, Strom SS, Selvan MS, Clayman GL, El-Naggar A, Lippman SM, Kripke ML, Ananthaswamy HN. PMID: 12538474.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    339. Cancer prevention science and practice. Cancer Res. 2002 Sep 15; 62(18):5119-25. Lippman SM, Hong WK. PMID: 12234971.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    340. Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. Clin Cancer Res. 2002 Sep; 8(9):2835-42. Singletary SE, Atkinson EN, Hoque A, Sneige N, Sahin AA, Fritsche HA, Lotan R, Lu T, Hittelman WN, Bevers TB, Stelling CB, Lippman SM. PMID: 12231524.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    341. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002 Jul 15; 95(2):322-30. Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK. PMID: 12124833.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    342. Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis. Clin Cancer Res. 2002 Jul; 8(7):2067-72. Clifford JL, Walch E, Yang X, Xu X, Alberts DS, Clayman GL, El-Naggar AK, Lotan R, Lippman SM. PMID: 12114405.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    343. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res. 2002 May 15; 62(10):2813-8. Wu X, Lippman SM, Lee JJ, Zhu Y, Wei QV, Thomas M, Hong WK, Spitz MR. PMID: 12019158.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    344. GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells. Cancer Res. 2002 Feb 15; 62(4):1178-83. Shureiqi I, Jiang W, Fischer SM, Xu X, Chen D, Lee JJ, Lotan R, Lippman SM. PMID: 11861401.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    345. Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy. Br J Cancer. 2002 Jan 21; 86(2):226-32. Shureiqi I, Cantor SB, Lippman SM, Brenner DE, Chernew ME, Fendrick AM. PMID: 11870511; PMCID: PMC2375190.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    346. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol. 2002 Jan 15; 20(2):364-70. Shin DM, Glisson BS, Khuri FR, Clifford JL, Clayman G, Benner SE, Forastiere AA, Ginsberg L, Liu D, Lee JJ, Myers J, Goepfert H, Lotan R, Hong WK, Lippman SM. PMID: 11786562.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCellsCTClinical Trials
    347. A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix. Clin Cancer Res. 2001 Nov; 7(11):3356-65. Follen M, Atkinson EN, Schottenfeld D, Malpica A, West L, Lippman S, Zou C, Hittelman WN, Lotan R, Hong WK. PMID: 11705848.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    348. SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial. J Urol. 2001 Oct; 166(4):1311-5. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C. PMID: 11547064.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    349. Lung cancer chemoprevention: an integrated approach. J Clin Oncol. 2001 Sep 15; 19(18 Suppl):74S-82S. Lippman SM, Spitz MR. PMID: 11560978.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    350. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control. 2001 Sep; 12(7):627-33. Hoque A, Albanes D, Lippman SM, Spitz MR, Taylor PR, Klein EA, Thompson IM, Goodman P, Stanford JL, Crowley JJ, Coltman CA, Santella RM. PMID: 11552710.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    351. Computerized image analysis of Ki-67 in ductal breast carcinoma in situ. Anal Quant Cytol Histol. 2001 Jun; 23(3):218-28. Menter DG, Hoque A, Motiwala N, Sahin AA, Sneige N, Lieberman R, Lippman SM. PMID: 11444192.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    352. p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas. Carcinogenesis. 2001 May; 22(5):729-35. El-Naggar AK, Lai S, Clayman GL, Mims B, Lippman SM, Coombes M, Luna MA, Lozano G. PMID: 11323391.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    353. Molecular markers of the risk of oral cancer. N Engl J Med. 2001 Apr 26; 344(17):1323-6. Lippman SM, Hong WK. PMID: 11320393.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    354. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst. 2001 Apr 18; 93(8):605-18. Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, Fry W, Graziano SL, Gandara DR, Okawara G, Woodhouse CL, Williams B, Perez C, Kim HW, Lotan R, Roth JA, Hong WK. PMID: 11309437.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCTClinical Trials
    355. Design considerations for efficient prostate cancer chemoprevention trials. Urology. 2001 Apr; 57(4 Suppl 1):205-12. Lee JJ, Lieberman R, Sloan JA, Piantadosi S, Lippman SM. PMID: 11295629.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    356. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):311-8. Khuri FR, Lee JS, Lippman SM, Lee JJ, Kalapurakal S, Yu R, Ro JY, Morice RC, Hong WK, Hittelman WN. PMID: 11319170.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    357. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res. 2001 Apr; 7(4):861-7. Khuri FR, Wu H, Lee JJ, Kemp BL, Lotan R, Lippman SM, Feng L, Hong WK, Xu XC. PMID: 11309334.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    358. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations. Urology. 2001 Apr; 57(4 Suppl 1):4-27. Lieberman R, Nelson WG, Sakr WA, Meyskens FL, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM. PMID: 11295590.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    359. Chromosome polysomy and histological characteristics in oral premalignant lesions. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):319-25. Kim J, Shin DM, El-Naggar A, Lee JS, Corrales C, Lippman SM, Hong WK, Hittelman WN. PMID: 11319171.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    360. Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma. Cancer. 2001 Apr 01; 91(7):1316-23. Shin DM, Khuri FR, Glisson BS, Ginsberg L, Papadimitrakopoulou VM, Clayman G, Lee JJ, Ang KK, Lippman SM, Hong WK. PMID: 11283932.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    361. Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):391-5. Clifford JL, Sabichi AL, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Lippman SM. PMID: 11319181.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    362. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Res. 2001 Mar 15; 61(6):2720-6. Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG. PMID: 11289153.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    363. Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2001 Mar; 10(3):249-59. Hoque A, Lippman SM, Boiko IV, Atkinson EN, Sneige N, Sahin A, Weber DM, Risin S, Lagios MD, Schwarting R, Colburn WJ, Dhingra K, Follen M, Kelloff GJ, Boone CW, Hittelman WN. PMID: 11303595.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    364. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):135-9. Clayman GL, Johnson CJ, Morrison W, Ginsberg L, Lippman SM. PMID: 11177029.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    365. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res. 2000 Dec 15; 60(24):6846-50. Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM. PMID: 11156377.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    366. Protease inhibitors in oral carcinogenesis and chemoprevention. Clin Cancer Res. 2000 Dec; 6(12):4599-603. Lippman SM, Matrisian LM. PMID: 11156207.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    367. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev. 2000 Nov; 9(11):1171-82. Menter DG, Sabichi AL, Lippman SM. PMID: 11097224.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    368. SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design. Prostate Cancer Prostatic Dis. 2000 Nov; 3(3):145-151. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C. PMID: 12497090.
      View in: PubMed   Mentions: 28     Fields:    
    369. Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. J Clin Oncol. 2000 Nov 01; 18(21 Suppl):9S-18S. Hong WK, Spitz MR, Lippman SM. PMID: 11060320.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    370. Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy. Clin Cancer Res. 2000 Oct; 6(10):3845-9. Shalev M, Thompson TC, Frolov A, Lippman SM, Hong WK, Fritsche H, Kadmon D. PMID: 11051228.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    371. Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1087-90. Singletary E, Lieberman R, Atkinson N, Sneige N, Sahin A, Tolley S, Colchin M, Bevers T, Stelling C, Fornage B, Fritsche H, Hittelman W, Kelloff G, Lippman SM. PMID: 11045792.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    372. Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev. 2000 Sep; 9(9):993-7. Clifford JL, Menter DG, Yang X, Walch E, Zou C, Clayman GL, Schaefer TS, El-Naggar AK, Lotan R, Lippman SM. PMID: 11008921.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    373. N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res. 2000 Aug; 6(8):2973-9. Kurie JM, Lee JS, Khuri FR, Mao L, Morice RC, Lee JJ, Walsh GL, Broxson A, Lippman SM, Ro JY, Kemp BL, Liu D, Fritsche HA, Xu X, Lotan R, Hong WK. PMID: 10955773.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    374. Primary cancer prevention trials. Hematol Oncol Clin North Am. 2000 Aug; 14(4):809-30. Hawk ET, Lippman SM. PMID: 10949775.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    375. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. J Clin Oncol. 2000 Aug; 18(15):2798-804. Khuri FR, Lotan R, Kemp BL, Lippman SM, Wu H, Feng L, Lee JJ, Cooksley CS, Parr B, Chang E, Walsh GL, Lee JS, Hong WK, Xu XC. PMID: 10920126.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    376. Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res. 2000 Aug; 6(8):3249-59. Duvic M, Helekar B, Schulz C, Cho M, DiSepio D, Hager C, DiMao D, Hazarika P, Jackson B, Breuer-McHam J, Young J, Clayman G, Lippman SM, Chandraratna RA, Robinson NA, Deucher A, Eckert RL, Nagpal S. PMID: 10955811.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    377. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. Semin Oncol. 2000 Aug; 27(4 Suppl 8):25-33. Khuri FR, Shin DM, Glisson BS, Lippman SM, Hong WK. PMID: 10952435.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    378. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst. 2000 Jul 19; 92(14):1136-42. Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, Lippman SM. PMID: 10904086.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    379. Chemoprevention of breast cancer. Breast Cancer Res Treat. 2000 Jul; 62(1):1-17. Brown PH, Lippman SM. PMID: 10989982.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    380. Lack of correlation between expression of retinoic acid receptor-beta and loss of heterozygosity on chromosome band 3p24 in esophageal cancer. Genes Chromosomes Cancer. 2000 Jun; 28(2):196-202. Qiu H, Lotan R, Lippman SM, Xu XC. PMID: 10825004.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    381. Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. Cancer Epidemiol Biomarkers Prev. 2000 Jun; 9(6):545-9. Li M, Lotan R, Levin B, Tahara E, Lippman SM, Xu XC. PMID: 10868686.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    382. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res. 2000 May; 6(5):1702-10. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, Benner SE, Xu XC, Lee JS, Papadimitrakopoulou VM, Geyer C, Perez C, Martin JW, El-Naggar AK, Lippman SM. PMID: 10815888.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansCells
    383. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Anticancer Res. 2000 May-Jun; 20(3A):1385-90. Wu H, Lotan R, Menter D, Lippman SM, Xu XC. PMID: 10928048.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    384. Cloning and characterization of the human retinoid X receptor alpha gene: conservation of structure with the mouse homolog. Biochem Biophys Res Commun. 2000 Mar 05; 269(1):54-7. Li G, Walch E, Yang X, Lippman SM, Clifford JL. PMID: 10694476.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    385. Lung cancer chemoprevention. Semin Surg Oncol. 2000 Mar; 18(2):100-5. Khuri FR, Lippman SM. PMID: 10657911.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    386. Advances in the development of retinoids as chemopreventive agents. J Nutr. 2000 02; 130(2S Suppl):479S-482S. Lippman SM, Lotan R. PMID: 10721933.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    387. Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression. J Natl Cancer Inst. 2000 Jan 05; 92(1):69-73. Shin DM, Mao L, Papadimitrakopoulou VM, Clayman G, El-Naggar A, Shin HJ, Lee JJ, Lee JS, Gillenwater A, Myers J, Lippman SM, Hittelman WN, Hong WK. PMID: 10620636.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    388. Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1087-94. Bacus JW, Boone CW, Bacus JV, Follen M, Kelloff GJ, Kagan V, Lippman SM. PMID: 10613341.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    389. Tamoxifen prevention of breast cancer: an instance of the fingerpost. J Natl Cancer Inst. 1999 Nov 03; 91(21):1809-19. Lippman SM, Brown PH. PMID: 10547388.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    390. Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis. Am J Pathol. 1999 Nov; 155(5):1519-23. Qiu H, Zhang W, El-Naggar AK, Lippman SM, Lin P, Lotan R, Xu XC. PMID: 10550308; PMCID: PMC1866961.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    391. National Cancer Institute--supported cancer chemoprevention research: coming of age. J Clin Oncol. 1999 Nov; 17(11 Suppl):53-62. McCaskill-Stevens W, Hawk ET, Flynn PJ, Lippman SM. PMID: 10630263.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    392. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 1999 Oct; 125(10):1083-9. Papadimitrakopoulou VA, Clayman GL, Shin DM, Myers JN, Gillenwater AM, Goepfert H, El-Naggar AK, Lewin JS, Lippman SM, Hong WK. PMID: 10522499.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    393. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J Natl Cancer Inst. 1999 Aug 04; 91(15):1317-21. Xu XC, Lee JS, Lee JJ, Morice RC, Liu X, Lippman SM, Hong WK, Lotan R. PMID: 10433621.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    394. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol. 1999 Aug; 17(8):2390-5. Garden AS, Glisson BS, Ang KK, Morrison WH, Lippman SM, Byers RM, Geara F, Clayman GL, Shin DM, Callender DL, Khuri FR, Goepfert H, Hong WK, Peters LJ. PMID: 10561301.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    395. Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. Cancer Res. 1999 May 15; 59(10):2493-8. Sun SY, Li W, Yue P, Lippman SM, Hong WK, Lotan R. PMID: 10344763.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    396. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res. 1999 May 15; 59(10):2477-83. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. PMID: 10344761.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    397. Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. Hum Pathol. 1999 Mar; 30(3):257-62. Sneige N, Lagios MD, Schwarting R, Colburn W, Atkinson E, Weber D, Sahin A, Kemp B, Hoque A, Risin S, Sabichi A, Boone C, Dhingra K, Kelloff G, Lippman S. PMID: 10088542.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    398. Paclitaxel-based chemotherapy for recurrent and/or metastatic head and neck squamous cell carcinoma: current and future directions. Semin Oncol. 1999 Feb; 26(1 Suppl 2):100-5. Shin DM, Lippman SM. PMID: 10190789.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    399. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells. Cancer Res. 1999 Jan 01; 59(1):14-8. Clifford JL, Menter DG, Wang M, Lotan R, Lippman SM. PMID: 9892176.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    400. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial. Gynecol Oncol. 1998 Dec; 71(3):386-90. Weiss GR, Liu PY, Alberts DS, Peng YM, Fisher E, Xu MJ, Scudder SA, Baker LH, Moore DF, Lippman SM. PMID: 9887236.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    401. Cancer chemoprevention. Part 2: Hormones, nonclassic antioxidant natural agents, NSAIDs, and other agents. Oncology (Williston Park). 1998 Dec; 12(12):1787-800; discussion 1802, 1805. Singh DK, Lippman SM. PMID: 9874850.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    402. Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants. Oncology (Williston Park). 1998 Nov; 12(11):1643-53, 1657-8; discussion 1659-60. Singh DK, Lippman SM. PMID: 9834941.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    403. Cancer chemoprevention: progress and promise. J Natl Cancer Inst. 1998 Oct 21; 90(20):1514-28. Lippman SM, Lee JJ, Sabichi AL. PMID: 9790544.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    404. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J Natl Cancer Inst. 1998 Oct 21; 90(20):1545-51. Mao L, El-Naggar AK, Papadimitrakopoulou V, Shin DM, Shin HC, Fan Y, Zhou X, Clayman G, Lee JJ, Lee JS, Hittelman WN, Lippman SM, Hong WK. PMID: 9790547.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    405. Retinoids in the chemoprevention of bladder cancer. Curr Opin Oncol. 1998 Sep; 10(5):479-84. Sabichi AL, Lerner SP, Grossman HB, Lippman SM. PMID: 9800121.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    406. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res. 1998 Jul; 4(7):1631-40. Zhou J, Mulshine JL, Ro JY, Avis I, Yu R, Lee JJ, Morice R, Lippman SM, Lee JS. PMID: 9676837.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    407. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol. 1998 Jun; 16(6):2221-32. Clayman GL, el-Naggar AK, Lippman SM, Henderson YC, Frederick M, Merritt JA, Zumstein LA, Timmons TM, Liu TJ, Ginsberg L, Roth JA, Hong WK, Bruso P, Goepfert H. PMID: 9626224.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCellsCTClinical Trials
    408. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol. 1998 Apr; 16(4):1325-30. Shin DM, Glisson BS, Khuri FR, Ginsberg L, Papadimitrakopoulou V, Lee JJ, Lawhorn K, Gillenwater AM, Ang KK, Clayman GL, Callender DL, Hong WK, Lippman SM. PMID: 9552033.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    409. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Semin Oncol. 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM. PMID: 9578061.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    410. Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. J Natl Cancer Inst. 1998 Feb 04; 90(3):243-5. Spitz MR, Lippman SM, Jiang H, Lee JJ, Khuri F, Hsu TC, Trizna Z, Schantz SP, Benner S, Hong WK. PMID: 9462683.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    411. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck. J Clin Oncol. 1998 Feb; 16(2):735-44. Brockstein B, Haraf DJ, Stenson K, Fasanmade A, Stupp R, Glisson B, Lippman SM, Ratain MJ, Sulzen L, Klepsch A, Weichselbaum RR, Vokes EE. PMID: 9469365.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    412. The effect of 13-cis-retinoic acid chemoprevention on human serum retinol levels. Cancer Detect Prev. 1998; 22(1):51-6. Lippman SM, Benner SE, Fritsche HA, Lee JS, Hong WK. PMID: 9466049.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    413. Phase I study of paclitaxel administered by ten-day continuous infusion. Invest New Drugs. 1998-1999; 16(3):237-43. Shade RJ, Pisters KM, Huber MH, Fossella F, Perez-Soler R, Shin DM, Kurie J, Glisson B, Lippman S, Lee JS. PMID: 10360603.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    414. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck. Semin Oncol. 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. Shin DM, Glisson BS, Khuri FR, Ginsberg L, Lawhorn K, Hong WK, Lippman SM. PMID: 9427263.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    415. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res. 1997 Nov 15; 57(22):4992-6. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R. PMID: 9371489.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    416. Prevention of nonmelanoma skin cancer. Standard and investigative approaches. Clin Plast Surg. 1997 Oct; 24(4):663-71. Farmer KL, Goller M, Lippman SM. PMID: 9342509.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    417. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev. 1997 Sep; 6(9):687-92. Spitz MR, McPherson RS, Jiang H, Hsu TC, Trizna Z, Lee JJ, Lippman SM, Khuri FR, Steffen-Batey L, Chamberlain RM, Schantz SP, Hong WK. PMID: 9298575.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    418. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997 Jun 18; 89(12):857-62. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR, Walsh GL, Hittelman WN, Hong WK. PMID: 9196251.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCells
    419. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention. Clin Cancer Res. 1997 Jun; 3(6):875-80. Shin DM, Xu XC, Lippman SM, Lee JJ, Lee JS, Batsakis JG, Ro JY, Martin JW, Hittelman WN, Lotan R, Hong WK. PMID: 9815762.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    420. Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene. 1997 Apr 17; 14(15):1799-803. Papadimitrakopoulou V, Izzo J, Lippman SM, Lee JS, Fan YH, Clayman G, Ro JY, Hittelman WN, Lotan R, Hong WK, Mao L. PMID: 9150385.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    421. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study. Cancer. 1997 Apr 01; 79(7):1279-86. Geara FB, Glisson BS, Sanguineti G, Tucker SL, Garden AS, Ang KK, Lippman SM, Clayman GL, Goepfert H, Peters LJ, Hong WK. PMID: 9083147.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    422. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Cancer J Sci Am. 1997 Mar-Apr; 3(2):92-9. Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM. PMID: 9099459.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    423. Retinoid-interferon therapy of solid tumors. Int J Cancer. 1997 Feb 07; 70(4):481-3. Lippman SM, Lotan R, Schleuniger U. PMID: 9033661.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    424. Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up. J Natl Cancer Inst. 1997 Feb 05; 89(3):257-8. Papadimitrakopoulou VA, Hong WK, Lee JS, Martin JW, Lee JJ, Batsakis JG, Lippman SM. PMID: 9017007.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    425. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J Natl Cancer Inst. 1997 Feb 05; 89(3):199-211. Khuri FR, Lippman SM, Spitz MR, Lotan R, Hong WK. PMID: 9017000.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    426. Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer. J Clin Oncol. 1997 Jan; 15(1):310-6. Fossella FV, Lippman SM, Shin DM, Tarassoff P, Calayag-Jung M, Perez-Soler R, Lee JS, Murphy WK, Glisson B, Rivera E, Hong WK. PMID: 8996158.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    427. Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity. Ann Oncol. 1997 Jan; 8(1):85-9. Dimery IW, Hong WK, Lee JJ, Guillory-Perez C, Pham F, Fritsche HA, Lippman SM. PMID: 9093712.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    428. Cancer prevention education at the M. D. Anderson Cancer Center. J Cancer Educ. 1997; 12(3):141-8. Chamberlain RM, Williams J, Levin B, Lippman SM. PMID: 9376250.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    429. Outcomes study of a course in breast-cancer screening. J Cancer Educ. 1997; 12(3):179-84. Ford M, Martin RD, Hilton LW, Ewert-Flannagan T, Corrigan GK, Johnson G, Hernandez MA, Sbach A, Lippman SM. PMID: 9376257.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    430. Retinoids, neoplasia and differentiation therapy. Cancer Chemother Biol Response Modif. 1997; 17:349-62. Lippman SM, Davies PJ. PMID: 9551220.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    431. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res. 1996 Dec 15; 56(24):5600-4. Mao L, El-Naggar AK, Fan YH, Lee JS, Lippman SM, Kayser S, Lotan R, Hong WK. PMID: 8971162.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    432. Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography. Int J Radiat Oncol Biol Phys. 1996 Dec 01; 36(5):1005-12. Garden AS, Lippman SM, Morrison WH, Glisson BS, Ang KK, Geara F, Hong WK, Peters LJ. PMID: 8985020.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    433. Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium. Clin Cancer Res. 1996 Oct; 2(10):1787-93. Kurie JM, Shin HJ, Lee JS, Morice RC, Ro JY, Lippman SM, Hittelman WN, Yu R, Lee JJ, Hong WK. PMID: 9816131.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    434. A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck. Am J Clin Oncol. 1996 Aug; 19(4):379-82. Huber MH, Lippman SM, Benner SE, Shirinian M, Dimery IW, Dunnington JS, Hong WK. PMID: 8677909.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    435. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med. 1996 Jun; 2(6):682-5. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, Hittelman W, Hong WK. PMID: 8640560.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansCells
    436. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst. 1996 Apr 17; 88(8):519-29. Shin DM, Lee JS, Lippman SM, Lee JJ, Tu ZN, Choi G, Heyne K, Shin HJ, Ro JY, Goepfert H, Hong WK, Hittelman WN. PMID: 8606380.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    437. Retinoids and interferons in non-melanoma skin cancer. J Investig Dermatol Symp Proc. 1996 Apr; 1(2):219-22. Lippman SM, Kalvakolanu DV, Lotan R. PMID: 9627720.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    438. Phase I trial of 9-cis retinoic acid in adults with solid tumors. Clin Cancer Res. 1996 Feb; 2(2):287-93. Kurie JM, Lee JS, Griffin T, Lippman SM, Drum P, Thomas MP, Weber C, Bader M, Massimini G, Hong WK. PMID: 9816171.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    439. Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy. J Clin Oncol. 1996 Feb; 14(2):503-13. Perez-Soler R, Fossella FV, Glisson BS, Lee JS, Murphy WK, Shin DM, Kemp BL, Lee JJ, Kane J, Robinson RA, Lippman SM, Kurie JM, Huber MH, Raber MN, Hong WK. PMID: 8636764.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    440. Detection of chromosome instability of tissue fields at risk: in situ hybridization. J Cell Biochem Suppl. 1996; 25:57-62. Hittelman WN, Kim HJ, Lee JS, Shin DM, Lippman SM, Kim J, Ro JY, Hong WK. PMID: 9027599.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    441. A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumors. Ann Oncol. 1996 Jan; 7(1):59-63. Huber MH, Lee JS, Newman RA, Fossella FV, Wester M, Hong WK, Lippman SM. PMID: 9081393.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    442. Olfactory neuroblastoma and neuroendocrine carcinoma of the anterior skull base: treatment results at the m.d. Anderson cancer center. Skull Base Surg. 1996; 6(1):1-8. Austin JR, Cebrun H, Kershisnik MM, El-Naggar AK, Garden AS, Demonte F, Ginsberg LE, Lippman SM, Goepfert H. PMID: 17170947; PMCID: PMC1656508.
      View in: PubMed   Mentions: 7  
    443. Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma. Am J Clin Oncol. 1995 Dec; 18(6):525-7. Moore DF, Pazdur R, Sugarman S, Jones D, Lippman SM, Bready B, Abbruzzese JL. PMID: 8526197.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    444. Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis. Cancer Epidemiol Biomarkers Prev. 1995 Dec; 4(8):871-6. Xu XC, Lee JS, Lippman SM, Ro JY, Hong WK, Lotan R. PMID: 8634660.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    445. Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression. Cancer Res. 1995 Dec 01; 55(23):5507-11. Xu XC, Zile MH, Lippman SM, Lee JS, Lee JJ, Hong WK, Lotan R. PMID: 7585623.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    446. Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck. Semin Oncol. 1995 Oct; 22(5 Suppl 12):22-5. Benner SE, Lippman SM, Huber MH, Hong WK. PMID: 7481857.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    447. Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin Cancer Res. 1995 Jul; 1(7):677-86. Ki Hong W, Lippman SM, Hittelman WN, Lotan R. PMID: 9816032.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    448. Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors. J Clin Oncol. 1995 Jun; 13(6):1501-8. Lee JS, Newman RA, Lippman SM, Fossella FV, Calayag M, Raber MN, Krakoff IH, Hong WK. PMID: 7751898.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    449. Chemoprevention of lung cancer. Chest. 1995 Jun; 107(6 Suppl):316S-321S. Benner SE, Lippman SM, Hong WK. PMID: 7781413.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    450. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med. 1995 May 25; 332(21):1405-10. Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK. PMID: 7723796.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    451. Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck. Curr Opin Oncol. 1995 May; 7(3):234-41. Lippman SM, Spitz MR, Huber MH, Hong WK. PMID: 7654825.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    452. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix. Gynecol Oncol. 1995 Mar; 56(3):382-6. Hallum AV, Alberts DS, Lippman SM, Inclan L, Shamdas GJ, Childers JM, Surwit EA, Modiano M, Hatch KD. PMID: 7705672.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    453. Current status of retinoid chemoprevention of lung cancer. Oncology (Williston Park). 1995 Mar; 9(3):205-10; discussion 210, 213-4, 216. Benner SE, Lippman SM, Hong WK. PMID: 7669514.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    454. Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer. J Clin Oncol. 1995 Mar; 13(3):645-51. Fossella FV, Lee JS, Shin DM, Calayag M, Huber M, Perez-Soler R, Murphy WK, Lippman S, Benner S, Glisson B, et al. PMID: 7884425.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    455. Phase II study of cisplatin, 5-fluorouracil and interferon-alpha in recurrent carcinoma of the cervix. Invest New Drugs. 1995; 13(1):73-6. Gonzales-de Léon C, Lippman SM, Kudelka AP, Edwards CL, Kavanagh JJ. PMID: 7499112.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    456. Biology and reversal of aerodigestive tract carcinogenesis. Cancer Treat Res. 1995; 74:89-115. Lippman SM, Clayman GL, Huber MH, Benner SE, Hong WK. PMID: 7779624.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    457. Cancer chemoprevention. J Natl Cancer Inst Monogr. 1995; (17):49-53. Hong WK, Lippman SM. PMID: 8573453.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    458. Screening at a health fair to identify subjects for an oral leukoplakia chemoprevention trial. J Cancer Educ. 1995; 10(2):88-90. Clayman GL, Chamberlain RM, Lee JJ, Lippman SM, Hong WK. PMID: 7669540.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    459. Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer. Ann Oncol. 1995 Jan; 6(1):83-5. Huber MH, Lippman SM, Benner SE, Shirinian M, Dimery IW, Earley CL, Winn RJ, Brooks J, Baez L, Hong WK. PMID: 7536031.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    460. p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Res. 1995 Jan 01; 55(1):16-9. Lippman SM, Shin DM, Lee JJ, Batsakis JG, Lotan R, Tainsky MA, Hittelman WN, Hong WK. PMID: 7805028.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    461. Co-carcinogenesis and field cancerization: oral lesions offer first signs. J Am Dent Assoc. 1995 Jan; 126(1):47-51. Hays GL, Lippman SM, Flaitz CM, Brown RS, Pang A, Devoll R, Hong WK. PMID: 7822645.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    462. Retinoids and chemoprevention: clinical and basic studies. J Cell Biochem Suppl. 1995; 22:1-10. Lippman SM, Heyman RA, Kurie JM, Benner SE, Hong WK. PMID: 8538183.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    463. Toxicity of isotretinoin in a chemoprevention trial to prevent second primary tumors following head and neck cancer. J Natl Cancer Inst. 1994 Dec 07; 86(23):1799-801. Benner SE, Pajak TF, Stetz J, Lippman SM, Hong WK, Schantz SP, Gallagher MJ, Shenouda G. PMID: 7966422.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    464. Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy. Int J Cancer. 1994 Nov 15; 59(4):457-9. Benner SE, Lippman SM, Wargovich MJ, Lee JJ, Velasco M, Martin JW, Toth BB, Hong WK. PMID: 7960211.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    465. Epidemiology, biology, and chemoprevention of aerodigestive cancer. Cancer. 1994 Nov 01; 74(9 Suppl):2719-25. Lippman SM, Spitz M, Trizna Z, Benner SE, Hong WK. PMID: 7954292.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    466. Retinoid lung cancer prevention. Lung Cancer. 1994 Nov; 11 Suppl 3:S71-8. Benner SE, Lippman SM, Hong WK. PMID: 7704516.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    467. Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors. Leukemia. 1994 Oct; 8(10):1622-5. Eisenhauer EA, Lippman SM, Kavanagh JJ, Parades-Espinoza M, Arnold A, Hong WK, Massimini G, Schleuniger U, Bollag W, Holdener EE, et al. PMID: 7934156.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    468. Retinoid chemoprevention of second primary tumors. Semin Hematol. 1994 Oct; 31(4 Suppl 5):26-30. Benner SE, Lippman SM, Hong WK. PMID: 7831582.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    469. Retinoic acid and interferon in human cancer: mechanistic and clinical studies. Semin Hematol. 1994 Oct; 31(4 Suppl 5):31-7. Moore DM, Kalvakolanu DV, Lippman SM, Kavanagh JJ, Hong WK, Borden EC, Paredes-Espinoza M, Krakoff IH. PMID: 7831583.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    470. Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer. J Clin Oncol. 1994 Jun; 12(6):1238-44. Fossella FV, Lee JS, Murphy WK, Lippman SM, Calayag M, Pang A, Chasen M, Shin DM, Glisson B, Benner S, et al. PMID: 7911160.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    471. Chemoprevention of head and neck cancer. Semin Oncol. 1994 Jun; 21(3):366-75. Huber MH, Lippman SM, Hong WK. PMID: 8209268.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    472. 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis. J Natl Cancer Inst. 1994 Jun 01; 86(11):859-61. Lippman SM, Donovan DT, Frankenthaler RA, Weber RS, Earley CL, Hong WK, Goepfert H. PMID: 8182767.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    473. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol. 1994 May; 12(5):937-45. Lee JS, Lippman SM, Benner SE, Lee JJ, Ro JY, Lukeman JM, Morice RC, Peters EJ, Pang AC, Fritsche HA, et al. PMID: 8164045.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    474. 13-cis-retinoic acid plus interferon-alpha in solid tumors: keeping the cart behind the horse. Ann Oncol. 1994 May; 5(5):391-3. Lippman SM, Hong WK. PMID: 8075044.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    475. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res. 1994 Apr 01; 54(7 Suppl):2025s-2028s. Lippman SM, Benner SE, Hong WK. PMID: 8137332.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    476. Cancer chemoprevention. J Clin Oncol. 1994 Apr; 12(4):851-73. Lippman SM, Benner SE, Hong WK. PMID: 8151328.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    477. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha]. Rev Invest Clin. 1994 Mar-Apr; 46(2):105-11. Paredes Espinoza M, Lippman SM, Kavanagh JJ, Delgadillo Madrueño F, Paredes Casillas P, Bañuelos Acosta O, Alvarez Márquez V, Buenrostro Ahued MA, de Alba Ayala I, Arias Castro G. PMID: 8052740.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    478. Second international cancer chemoprevention conference. Cancer Res. 1994 Feb 01; 54(3):854-6. Benner SE, Pastorino U, Lippman SM, Hong WK. PMID: 7905788.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    479. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl Cancer Inst. 1994 Jan 19; 86(2):140-1. Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK. PMID: 8271298.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    480. Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck. Invest New Drugs. 1994; 12(4):327-31. Huber MH, Dimery IW, Benner SE, Lippman SM, Shirinian M, Esparaz B, Frenning D, Guillory-Perez C, Hong WK. PMID: 7775135.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    481. Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors. Leukemia. 1994; 8 Suppl 3:S38-41. Eisenhauer EA, Lippman SM, Kavanagh JJ, Parades-Espinoza M, Arnold A, Hong WK, Massimini G, Schleuniger U, Bollag W, Holdener EE, et al. PMID: 7808023.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    482. Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb; 3(1):73-6. Benner SE, Wargovich MJ, Lippman SM, Fisher R, Velasco M, Winn RJ, Hong WK. PMID: 8118389.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    483. Chemoprevention of second primary tumours: a model for intervention trials. Eur J Cancer. 1994; 30A(6):727-9. Benner SE, Lippman SM, Hong WK. PMID: 7917527.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    484. Phase I/II study of cisplatin, 5-fluorouracil and alpha-interferon for recurrent carcinoma of the head and neck. Invest New Drugs. 1994; 12(3):223-9. Huber MH, Shirinian M, Lippman SM, Dimery IW, Frankenthaler RA, Hong WK. PMID: 7896541.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    485. Evolution of aerodigestive tract 13-cis-retinoid acid chemoprevention: the M.D. Anderson experience. Leukemia. 1994; 8 Suppl 3:S33-7. Hong WK, Benner SE, Lippman SM. PMID: 7808022.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    486. Potential of retinoids in cancer prevention. Cancer Treat Rev. 1994 Jan; 20(1):1-10. Kurie JM, Lippman SM, Hong WK. PMID: 8293427.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    487. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience. Head Neck. 1994 Jan-Feb; 16(1):39-44. Shirinian MH, Weber RS, Lippman SM, Dimery IW, Earley CL, Garden AS, Michaelson J, Morrison WH, Kramer A, Byers R, et al. PMID: 7510276.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    488. Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion. J Natl Cancer Inst. 1993 Dec 01; 85(23):1951-4. Lee JS, Kim SY, Hong WK, Lippman SM, Ro JY, Gay ML, Hittelman WN. PMID: 8230287.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    489. Recent advances in head and neck cancer--larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 1993 Nov 01; 53(21):5113-20. Hong WK, Lippman SM, Wolf GT. PMID: 8221647.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    490. Retinoids in chemoprevention of head and neck carcinogenesis. Prev Med. 1993 Sep; 22(5):693-700. Lippman SM, Benner SE, Hong WK. PMID: 8234209.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    491. Chemoprevention. Strategies for the control of cancer. Cancer. 1993 Aug 01; 72(3 Suppl):984-90. Lippman SM, Benner SE, Hong WK. PMID: 8334674.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    492. Not yet standard: retinoids versus second primary tumors. J Clin Oncol. 1993 Jul; 11(7):1204-7. Lippman SM, Hong WK. PMID: 8315418.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    493. Chemoprevention as a form of cancer control. J Am Dent Assoc. 1993 Jul; 124(7):243-6. Toth BB, Martin JW, Lippman SM, Hong WK. PMID: 8335795.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    494. Metastatic adenocarcinoma of the endometrium treated with 13-cis-retinoic acid plus interferon-alpha. Anticancer Drugs. 1993 Jun; 4(3):335-7. Kudelka AP, Freedman RS, Edwards CL, Lippman SM, Tornos CS, Krakoff IH, Kavanagh JJ. PMID: 8358060.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    495. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors. J Clin Oncol. 1993 May; 11(5):959-66. Lee JS, Newman RA, Lippman SM, Huber MH, Minor T, Raber MN, Krakoff IH, Hong WK. PMID: 8487058.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    496. Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest. 1993 May; 103(5):1429-32. Peters EJ, Morice R, Benner SE, Lippman S, Lukeman J, Lee JS, Ro JY, Hong WK. PMID: 8486022.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    497. 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix. J Natl Cancer Inst. 1993 Mar 17; 85(6):499-500. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueño F, Paredes-Casillas P, Hong WK, Massimini G, Holdener EE, Krakoff IH. PMID: 8445678.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    498. Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer. Anticancer Drugs. 1993 Feb; 4(1):33-6. Rinaldi DA, Lippman SM, Burris HA, Chou C, Von Hoff DD, Hong WK. PMID: 8457712.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    499. Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma. Invest New Drugs. 1993 Feb; 11(1):39-43. Dhingra K, Papadopoulos N, Lippman S, Lotan R, Legha SS. PMID: 8349434.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    500. Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer. Invest New Drugs. 1993 Feb; 11(1):87-90. Munshi NC, Seitz DE, Fossella F, Lippman SM, Einhorn LH. PMID: 8394298.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    501. Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer. Invest New Drugs. 1993 Feb; 11(1):57-60. Voravud N, Lippman SM, Weber RS, Rodriquez GI, Yee D, Dimery IW, Earley CL, Von Hoff DD, Hong WK. PMID: 8349437.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    502. Head and neck cancer. N Engl J Med. 1993 Jan 21; 328(3):184-94. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. PMID: 8417385.
      View in: PubMed   Mentions: 338     Fields:    Translation:Humans
    503. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med. 1993 Jan 07; 328(1):15-20. Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GL, Goepfert H, Hong WK. PMID: 8416267.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCTClinical Trials
    504. Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study. J Natl Cancer Inst. 1993 Jan 06; 85(1):44-7. Benner SE, Winn RJ, Lippman SM, Poland J, Hansen KS, Luna MA, Hong WK. PMID: 8416256.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    505. Retinoic acid and interferon combination studies in human cancer. Eur J Cancer. 1993; 29A Suppl 5:S9-13. Lippman SM, Glisson BS, Kavanagh JJ, Lotan R, Hong WK, Paredes-Espinoza M, Hittelman WN, Holdener EE, Krakoff IH. PMID: 8260265.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    506. Chemoprevention strategies in lung carcinogenesis. Chest. 1993 Jan; 103(1 Suppl):15S-19S. Lippman SM, Benner SE, Hong WK. PMID: 8416769.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    507. Micronuclei: a potential intermediate marker for chemoprevention of aerodigestive tract cancer. J Cell Biochem Suppl. 1993; 17F:250-4. Benner SE, Wargovich MJ, Lippman SM, Hong WK. PMID: 8412201.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    508. The incidence of second primary tumors in long-term survivors of small-cell lung cancer. J Clin Oncol. 1992 Oct; 10(10):1519-24. Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK. PMID: 1328547.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    509. Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesis. Int J Cancer. 1992 Aug 19; 52(1):44-7. Benner SE, Lippman SM, Wargovich MJ, Velasco M, Peters EJ, Morice RC, Hong WK. PMID: 1500226.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    510. Current status of chemoprevention of head and neck cancer. Oncology (Williston Park). 1992 Aug; 6(8):61-6; discussion 66-8, 71 passim. Benner SE, Lippman SM, Hong WK. PMID: 1386997.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    511. A phase II study of interleukin-2 and interferon-alpha in head and neck cancer. Invest New Drugs. 1992 Aug; 10(3):217-23. Schantz SP, Dimery I, Lippman SM, Clayman GL, Pellegrino C, Morice R. PMID: 1428731.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    512. Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer. J Natl Cancer Inst. 1992 Jul 01; 84(13):1039-40. Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. PMID: 1318977.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    513. Intervention approaches in early lung cancer and premalignant disease: breakout group report. Cancer Res. 1992 May 01; 52(9 Suppl):2767s-2768s. Ihde DC, Lippman S. PMID: 1563011.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    514. Determination of biomarkers for intermediate end points in chemoprevention trials. Cancer Res. 1992 May 01; 52(9 Suppl):2707s-2710s. Lee JS, Lippman SM, Hong WK, Ro JY, Kim SY, Lotan R, Hittelman WN. PMID: 1348662.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    515. Chemoprevention strategies for lung and upper aerodigestive tract cancer. Cancer Res. 1992 May 01; 52(9 Suppl):2758s-2763s. Benner SE, Lippman SM, Hong WK. PMID: 1563008.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    516. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst. 1992 Feb 19; 84(4):235-41. Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU, Hong WK. PMID: 1734084.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCTClinical Trials
    517. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst. 1992 Feb 19; 84(4):241-5. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueño F, Paredes-Casillas P, Hong WK, Holdener E, Krakoff IH. PMID: 1734085.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    518. Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials. J Cell Biochem Suppl. 1992; 16G:33-8. Benner SE, Hong WK, Lippman SM, Lee JS, Hittelman WM. PMID: 1469903.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    519. Chemoprevention of aerodigestive epithelial cancers. Adv Exp Med Biol. 1992; 320:151-61. Lippman SM, Hong WK. PMID: 1442280.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    520. A quantitatively scored cancer-risk assessment tool: its development and use. J Cancer Educ. 1992; 7(1):15-36. Lippman SM, Bassford TL, Meyskens FL. PMID: 1571244.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    521. Retinoid chemoprevention of upper aerodigestive tract carcinogenesis. Important Adv Oncol. 1992; 93-109. Lippman SM, Hong WK. PMID: 1316312.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCTClinical Trials
    522. 13-cis-retinoic acid and cancer chemoprevention. J Natl Cancer Inst Monogr. 1992; (13):111-5. Lippman SM, Hong WK. PMID: 1389684.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    523. Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases. Invest New Drugs. 1991 Nov; 9(4):357-9. Fossella FV, Lippman SM, Seitz DE, Alberts DS, Taylor CW, Wiltshaw E, Hardy J, O'Brien M, Haynes TR, Wolen RL. PMID: 1804813.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    524. Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer. Cancer. 1991 Sep 01; 68(5):959-64. Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. PMID: 1655220.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    525. Beta-carotene didn't prevent cancer: what's up doc? J Natl Cancer Inst. 1991 Aug 07; 83(15):1110-1. Lippman SM, Hong WK. PMID: 1750915.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    526. Chemoprevention in head and neck cancer. Hematol Oncol Clin North Am. 1991 Aug; 5(4):783-95. Heyne KE, Lippman SM, Hong WK. PMID: 1890067.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    527. Cancer risk reduction counseling: a computer-assisted curriculum. Am J Prev Med. 1991 Jul-Aug; 7(4):244-7. Gordon PR, Bassford TL, Lippman SM. PMID: 1756062.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    528. Recent advances in cancer chemoprevention. Cancer Cells. 1991 Feb; 3(2):59-65. Lippman SM, Hittelman WN, Lotan R, Pastorino U, Hong WK. PMID: 1674206.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    529. Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype. Leuk Lymphoma. 1991; 6(1):31-8. Rybski JA, Spier CM, Miller TP, Lippman SM, McGee DL, Grogan TM. PMID: 27457573.
      View in: PubMed   Mentions: 6     Fields:    
    530. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990 Sep 20; 323(12):795-801. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, et al. PMID: 2202902.
      View in: PubMed   Mentions: 192     Fields:    Translation:HumansCTClinical Trials
    531. Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma. Invest New Drugs. 1990 Aug; 8(3):317-9. Modiano MR, Dalton WS, Lippman SM, Joffe L, Booth AR, Meyskens FL. PMID: 2148744.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    532. Ocular toxic effects of fenretinide. J Natl Cancer Inst. 1990 Jun 20; 82(12):1063. Modiano MR, Dalton WS, Lippman SM, Joffe L, Booth AR, Meyskens FL. PMID: 2140863.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    533. Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma. J Clin Oncol. 1990 Jun; 8(6):986-93. Slymen DJ, Miller TP, Lippman SM, Spier CM, Kerrigan DP, Rybski JA, Rangel CS, Richter LC, Grogan TM. PMID: 2140855.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    534. Bronchial micronuclei as a marker of an early stage of carcinogenesis in the human tracheobronchial epithelium. Int J Cancer. 1990 May 15; 45(5):811-5. Lippman SM, Peters EJ, Wargovich MJ, Stadnyk AN, Dixon DO, Dekmezian RH, Loewy JW, Morice RC, Cunningham JE, Hong WK. PMID: 2335384.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    535. Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course. Mod Pathol. 1990 May; 3(3):361-7. Lippman SM, Spier CM, Miller TP, Slymen DJ, Rybski JA, Grogan TM. PMID: 2194216.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    536. Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst. 1990 Apr 04; 82(7):555-60. Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK. PMID: 2179569.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    537. The evaluation of micronuclei as an intermediate endpoint of bronchial carcinogenesis. Prog Clin Biol Res. 1990; 339:165-77. Lippman SM, Peters EJ, Wargovich MJ, Dixon DO, Dekmezian RH, Cunningham JE, Loewy JW, Morice RC, Hong WK. PMID: 1697414.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    538. Modulation by 13-cis retinoic acid of biologic markers as indicators of intermediate endpoints in human oral carcinogenesis. Prog Clin Biol Res. 1990; 339:179-91. Lippman SM, Toth BB, Batsakis JG, Weber RS, McCarthy KS, Hays GL, Wargovich MJ, Lee JS, Thacher S, Lotan R, et al. PMID: 1697415.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    539. Chemoprevention of upper aerodigestive tract cancers: a report of the third Upper Aerodigestive Cancer Task Force workshop. Head Neck. 1990 Jan-Feb; 12(1):5-20. Lippman SM, Lee JS, Lotan R, Hong WK. PMID: 2404905.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCTClinical Trials
    540. Advanced basal and squamous cell carcinomas of the skin of the head and neck. Cancer Treat Res. 1990; 52:61-81. Weber RS, Lippman SM, McNeese MD. PMID: 1976376.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    541. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys. 1989 Sep; 17(3):691-4. Lippman SM, Hong WK. PMID: 2674081.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    542. Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck. Prev Med. 1989 Sep; 18(5):740-8. Lippman SM, Garewal HS, Meyskens FL. PMID: 2694167.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    543. Results of the use of vitamin A and retinoids in cutaneous malignancies. Pharmacol Ther. 1989; 40(1):107-22. Lippman SM, Meyskens FL. PMID: 2645584.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    544. Quantitative assessment of cancer risk. Tex Med. 1988 Oct; 84(10):48-53. Lippman SM, Bassford TL, Meyskens FL. PMID: 3068823.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    545. The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma. Am J Pathol. 1988 Oct; 133(1):118-26. Spier CM, Grogan TM, Lippman SM, Slymen DJ, Rybski JA, Miller TP. PMID: 3140668; PMCID: PMC1880635.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    546. Vitamin A derivatives in the prevention and treatment of human cancer. J Am Coll Nutr. 1988 Aug; 7(4):269-84. Lippman SM, Meyskens FL. PMID: 3062055.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    547. Nonsurgical treatments for skin cancer: retinoids and alpha-interferon. J Dermatol Surg Oncol. 1988 Aug; 14(8):862-9. Lippman SM, Shimm DS, Meyskens FL. PMID: 3294268.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    548. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood. 1988 Aug; 72(2):436-41. Lippman SM, Miller TP, Spier CM, Slymen DJ, Grogan TM. PMID: 3261181.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    549. HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma. J Clin Invest. 1988 Jul; 82(1):370-2. Miller TP, Lippman SM, Spier CM, Slymen DJ, Grogan TM. PMID: 3392214; PMCID: PMC303519.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    550. Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration. Cancer. 1988 Jun 15; 61(12):2571-7. Lippman SM, Alberts DS, Slymen DJ, Weiner S, Aristizabal SA, Luditch A, Davis JR, Surwit EA. PMID: 3365677.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    551. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood. 1988 Apr; 71(4):1157-60. Grogan TM, Lippman SM, Spier CM, Slymen DJ, Rybski JA, Rangel CS, Richter LC, Miller TP. PMID: 3281723.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    552. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial. Invest New Drugs. 1988 Apr; 6(1):51-6. Lippman SM, Kessler JF, Al-Sarraf M, Alberts DS, Itri LM, Mattox D, Von Hoff DD, Loescher L, Meyskens FL. PMID: 3165972.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    553. Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survival. Cancer. 1988 Feb 01; 61(3):517-24. Spier CM, Lippman SM, Miller TP, Grogan TM. PMID: 3257404.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    554. Retinoids as anticancer agents. Prog Clin Biol Res. 1988; 259:229-44. Lippman SM, Meyskens FL. PMID: 3283747.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    555. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med. 1987 Oct; 107(4):499-502. Lippman SM, Meyskens FL. PMID: 3477106.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    556. Danazol in the treatment of myelodysplastic syndromes. Eur J Haematol. 1987 Oct; 39(4):346-8. Buzaid AC, Garewal HS, Lippman SM, Durie BG, Katakkar SB, Greenberg BR. PMID: 3319676.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    557. Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potential. Am J Med. 1987 Sep; 83(3):523-32. Buzaid AC, Lippman SM, Miller TP. PMID: 2444105.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    558. Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat Rep. 1987 May; 71(5):493-515. Lippman SM, Kessler JF, Meyskens FL. PMID: 3552220.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    559. Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treat Rep. 1987 Apr; 71(4):391-405. Lippman SM, Kessler JF, Meyskens FL. PMID: 3548957.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    560. Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer. 1987 Mar 01; 59(5):936-9. Lippman SM, Grogan TM, Spier CM, Koopmann CF, Gall EP, Shimm DS, Durie BG. PMID: 3493060.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    561. Radiation therapy salvage of Hodgkin's disease following chemotherapy failure. J Clin Oncol. 1987 Jan; 5(1):38-45. Fox KA, Lippman SM, Cassady JR, Heusinkveld RS, Miller TP. PMID: 3806158.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    562. Cranial metastases from prostate cancer simulating meningioma: report of two cases and review of the literature. Neurosurgery. 1986 Nov; 19(5):820-3. Lippman SM, Buzaid AC, Iacono RP, Steinbronn DV, Stanisic TH, Rennels MA, Yang PJ, Garewal HS, Ahmann FR. PMID: 3785633.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    563. Abnormal septal Q waves in sickle cell disease. Prevalence and causative factors. Chest. 1985 Oct; 88(4):543-8. Lippman SM, Niemann JT, Thigpen T, Ginzton LE, Laks MM. PMID: 4042704.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    564. Mitral valve prolapse in sickle cell disease: manifestation of a generalized connective tissue disorder. Am J Hematol. 1985 May; 19(1):1-12. Lippman SM, Abergel RP, Ginzton LE, Uitto J, Tanaka KR, Miyamoto EK, Laks MM. PMID: 3985003.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    565. Mitral valve prolapse in sickle cell disease. Presumptive evidence for a linked connective tissue disorder. Arch Intern Med. 1985 Mar; 145(3):435-8. Lippman SM, Ginzton LE, Thigpen T, Tanaka KR, Laks MM. PMID: 3977511.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    566. The evaluation of patients with Eales' disease. Retina. 1983 Fall-Winter; 3(4):243-8. Renie WA, Murphy RP, Anderson KC, Lippman SM, McKusick VA, Proctor LR, Shimizu H, Patz A, Fine SL. PMID: 6675099.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    567. Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenic purpura, and systemic lupus erythematosus. Am J Med. 1982 Dec; 73(6):827-40. Lippman SM, Arnett FC, Conley CL, Ness PM, Meyers DA, Bias WB. PMID: 6756137.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    568. Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow. N Engl J Med. 1982 Feb 04; 306(5):281-6. Conley CL, Lippman SM, Ness PM, Petz LD, Branch DR, Gallagher MT. PMID: 7054700.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    569. The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. J Clin Endocrinol Metab. 1982 Feb; 54(2):233-40. Lippman SM, Mendelsohn G, Trump DL, Wells SA, Baylin SB. PMID: 6798062.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    570. Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency. JAMA. 1980 Oct 10; 244(15):1688-90. Conley CL, Lippman SM, Ness P. PMID: 7411826.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsPHPublic Health
    571. Steroid levels in cancer of the prostate--markers of tumor differentiation and adequacy of anti-androgen therapy. Prog Clin Biol Res. 1979; 33:103-11. Geller J, Albert J, Nachtsheim D, Loza D, Lippman S. PMID: 93747.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    572. A general method for the large-scale isolation of polysomes and messenger RNA applied to MOPC 21 mouse myeloma tumors. Anal Biochem. 1977 Sep; 82(1):115-29. Wall R, Lippman S, Toth K, Fedoroff N. PMID: 907116.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Scott's Networks
    Concepts (1313)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (120)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California